<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS100941</article-id>
<article-id pub-id-type="doi">10.1101/2020.10.22.349415</article-id>
<article-id pub-id-type="archive">PPR229360</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Broad transcriptional dysregulation of brain and choroid plexus cell
                    types with COVID-19</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Yang</surname>
<given-names>Andrew C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Kern</surname>
<given-names>Fabian</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Losada</surname>
<given-names>Patricia M.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maat</surname>
<given-names>Christina A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schmartz</surname>
<given-names>Georges</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fehlmann</surname>
<given-names>Tobias</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaum</surname>
<given-names>Nicholas</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Davis P.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Calcuttawala</surname>
<given-names>Kruti</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vest</surname>
<given-names>Ryan T.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gate</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berdnik</surname>
<given-names>Daniela</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McNerney</surname>
<given-names>M. Windy</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Channappa</surname>
<given-names>Divya</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cobos</surname>
<given-names>Inma</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ludwig</surname>
<given-names>Nicole</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schulz-Schaeffer</surname>
<given-names>Walter J.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keller</surname>
<given-names>Andreas</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wyss-Coray</surname>
<given-names>Tony</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Bioengineering, Stanford University School of
                Medicine, Stanford, California, USA</aff>
<aff id="A2">
<label>2</label>ChEM-H, Stanford University, Stanford, California, USA</aff>
<aff id="A3">
<label>3</label>Department of Neurology and Neurological Sciences, Stanford
                University School of Medicine, Stanford, California, USA</aff>
<aff id="A4">
<label>4</label>Chair for Clinical Bioinformatics, Saarland University, 66123
                Saarbrucken, SL, Germany</aff>
<aff id="A5">
<label>5</label>Department of Psychiatry, Stanford University School of Medicine,
                Stanford, California, USA</aff>
<aff id="A6">
<label>6</label>Department of Pathology, Stanford University School of Medicine,
                Stanford, California, USA</aff>
<aff id="A7">
<label>7</label>Department of Human Genetics, Saarland University, 66421
                Homburg/Saar, Germany</aff>
<aff id="A8">
<label>8</label>Institute for Neuropathology, Saarland University Hospital and
                Medical Faculty of Saarland University</aff>
<aff id="A9">
<label>9</label>Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA,
                USA</aff>
<aff id="A10">
<label>10</label>Paul F. Glenn Center for the Biology of Aging, Stanford University
                School of Medicine, Stanford, California, USA</aff>
<author-notes>
<corresp id="CR1">
                    <label>*</label>Correspondence and requests for materials should be addressed to
                    A.K. or T.W.-C. (<email>andreas.keller@ccb.uni-saarland.de</email>,
                        <email>twc@stanford.edu</email>).</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>10</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>22</day>
<month>10</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC
                            4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">Though SARS-CoV-2 primarily targets the respiratory system, it is
                    increasingly appreciated that patients may suffer neurological symptoms of
                    varied severity<sup>
<xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref>
</sup>. However, an unbiased understanding of the molecular processes across
                    brain cell types that could contribute to these symptoms in COVID-19 patients is
                    still missing. Here, we profile 47,678 droplet-based single-nucleus
                    transcriptomes from the frontal cortex and choroid plexus across 10 non-viral, 4
                    COVID-19, and 1 influenza patient. We complement transcriptomic data with
                    immunohistochemical staining for the presence of SARS-CoV-2. We find that all
                    major cortex parenchymal and choroid plexus cell types are affected
                    transcriptionally with COVID-19. This arises, in part, from SARS-CoV-2 infection
                    of the cortical brain vasculature, meninges, and choroid plexus, stimulating
                    increased inflammatory signaling into the brain. In parallel, peripheral immune
                    cells infiltrate the brain, microglia activate programs mediating the
                    phagocytosis of live neurons, and astrocytes dysregulate genes involved in
                    neurotransmitter homeostasis. Among neurons, layer 2/3 excitatory
                    neurons—evolutionarily expanded in humans<sup>
<xref ref-type="bibr" rid="R4">4</xref>
</sup>—show a specific downregulation of genes encoding major SNARE and synaptic
                    vesicle components, predicting compromised synaptic transmission. These
                    perturbations are not observed in terminal influenza. Many COVID-19 gene
                    expression changes are shared with those in chronic brain disorders and reside
                    in genetic variants associated with cognitive function, schizophrenia, and
                    depression. Our findings and public dataset provide a molecular framework and
                    new opportunities to understand COVID-19 related neurological disease.</p>
</abstract>
</article-meta>
</front>
<body>
<p id="P2">Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiologic agent
            of the COVID-19 global pandemic, has as of October 2020 infected over 40 million people
            and caused over a million deaths worldwide (<ext-link ext-link-type="uri" xlink:href="https://www.worldometers.info/coronavirus/">worldometers.info/coronavirus</ext-link>). Though
            SARS-CoV-2 primarily targets the respiratory system, it is increasingly appreciated that
            COVID-19 patients can suffer neurological and psychiatric symptoms of varied severity,
            depending on SARS-CoV-2 mechanisms as well as other variables, such as co-morbidities
            and clinical care<sup>
<xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R5">5</xref>
</sup>. Central nervous system (CNS) symptoms range from loss of smell and headache to
            memory loss, encephalitis, stroke, difficulty concentrating, and persistent fatigue<sup>
<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R6">6</xref>–<xref ref-type="bibr" rid="R8">8</xref>
</sup>. Symptoms are especially frequent and prominent in the over 20% of COVID-19
            patients that require hospitalization<sup>
<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R9">9</xref>–<xref ref-type="bibr" rid="R11">11</xref>
</sup>. With lingering CNS symptoms documented in Severe Acute Respiratory Syndrome
            (SARS) and Middle East Respiratory Syndrome (MERS) survivors<sup>
<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R14">14</xref>
</sup>, it remains to be seen whether such chronic symptoms will emerge in COVID-19
            survivors.</p>
<p id="P3">Cellular and molecular approaches are required to understand the neurological
            changes that may contribute to symptoms reported in COVID-19 patients. Fundamentally,
            pathology can arise from the direct infection of neurons and glia or indirectly from
            peripheral infection and its attendant immune response<sup>
<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R16">16</xref>
</sup>. Viral RNA has been detected in the olfactory mucosa and cerebrospinal fluid
            (CSF) in some cases, but the consequences for brain cells remain unclear<sup>
<xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R20">20</xref>
</sup>. Several reports using elegant <italic>in vitro</italic> culture systems, such as
            neuronal organoids, have reached conflicting conclusions regarding the potential for
            SARS-CoV-2 neuroinvasion<sup>
<xref ref-type="bibr" rid="R21">21</xref>–<xref ref-type="bibr" rid="R26">26</xref>
</sup>. The physiological relevance of such cultured systems, from the viral titers
            applied to their fidelity to actual patient brains, also remains unclear<sup>
<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref>
</sup>. Missing so far is an unbiased view of the molecular and cellular perturbations
            across brain cell types in COVID-19 patients. This is in part because high-quality human
            brain tissue from patients for such studies is largely inaccessible<sup>
<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref>
</sup>. Furthermore, several brain regions highly relevant to COVID-19, such as the
            choroid plexus<sup>
<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref>
</sup>, have not yet been successfully profiled in humans at single-cell resolution, in
            health or disease<sup>
<xref ref-type="bibr" rid="R29">29</xref>
</sup>.</p>
<p id="P4">Here, we profile 47,678 droplet-based single-nucleus transcriptomes from the
            frontal cortex and choroid plexus across 10 non-viral, 4 COVID-19, and 1 influenza
            patient (<xref ref-type="fig" rid="F1">Fig. 1a</xref>). We complement transcriptomic
            data with immunohistochemical staining for the presence of SARS-CoV-2. These data—which
            includes the first, to our knowledge, single-cell view of neurological changes in
            COVID-19 and of the human choroid plexus in general—provide a molecular framework for
            how SARS-CoV-2 affects the brain without requiring direct neuroinvasion; reveals the
            major pathways and cell types perturbed; and highlights associations with chronic CNS
            diseases potentially pertinent to COVID-19 survivors. We created an interactive data
            browser (<italic>
<ext-link ext-link-type="uri" xlink:href="https://twc-stanford.shinyapps.io/scRNA_Brain_COVID19">https://twc-stanford.shinyapps.io/scRNA_Brain_COVID19</ext-link>
</italic>), which will be updated as more patient samples become available, to provide a
            resource for researchers to further dissect the molecular mechanisms of SARS-CoV-2's
            impacts on the brain.</p>
<sec id="S1">
<title>Cell type-specific gene expression changes in the COVID-19 brain</title>
<p id="P5">We aimed to gain insight into the cell type–specific transcriptomic effects
                of COVID-19 on the brain by performing unbiased single-nucleus RNA sequencing
                (snRNA-seq) of 15 fresh-frozen postmortem medial frontal cortex and lateral
                ventricle choroid plexus samples from 10 non-viral, 4 COVID-19, and 1 influenza
                patient of similar clinical course as the COVID-19 patients (<xref ref-type="supplementary-material" rid="SD1">Extended Data Table 1</xref>). Our
                sample sizes were similar to those reported in previous snRNA-seq studies<sup>
<xref ref-type="bibr" rid="R30">30</xref>–<xref ref-type="bibr" rid="R32">32</xref>
</sup>. Samples in the control and COVID-19 groups were between 58 and 91 years old
                and matched for tissue dissection area and RNA quality (<xref ref-type="fig" rid="F7">Extended Data Fig. 1</xref>, <xref ref-type="supplementary-material" rid="SD1">Extended Data Table 1</xref>). Cause of death for COVID-19 and
                influenza patients was consistently interstitial pneumonia after more than two weeks
                of mechanical ventilation. Two COVID-19 patients experienced objective neurological
                symptoms during care (<xref ref-type="supplementary-material" rid="SD1">Extended
                    Data Table 1</xref>). Samples were not confounded by technical or batch
                artifacts (<xref ref-type="fig" rid="F8">Extended Data Fig. 2</xref>).</p>
<p id="P6">To begin, we generated 23,626 single-nuclei gene expression profiles from the
                medial frontal cortex (4 non-viral, 4 COVID-19, 1 influenza)—and detected a median
                of 1,486 genes per nucleus, a yield that is in line with recent snRNA-seq studies
                    (<xref ref-type="fig" rid="F1">Fig. 1b</xref>, <xref ref-type="fig" rid="F7">Extended Data Fig. 1</xref>)<sup>
<xref ref-type="bibr" rid="R31">31</xref>–<xref ref-type="bibr" rid="R34">34</xref>
</sup>. We performed unbiased clustering of nuclear profiles to identify and
                annotate 8 cell types, including subtypes of excitatory neurons and interneurons.
                Each annotated cell type expressed previously established marker genes (<xref ref-type="fig" rid="F9">Extended Data Fig. 3</xref>): excitatory neurons (e.g.,
                marked by <italic>CBLN2</italic> and <italic>NRGN</italic>), inhibitory neurons
                    (<italic>GAD1</italic>), astrocytes (<italic>AQP4</italic>), oligodendrocytes
                    (<italic>MBP</italic> and <italic>ST18</italic>), microglia
                    (<italic>DOCK8</italic>), oligodendrocyte progenitor cells
                    (<italic>VCAN</italic>), maturing neurons (<italic>DACH1</italic>), and
                endothelial cells (<italic>LEPR</italic>)—though this latter population also
                contains mixed markers for vascular mural pericytes and smooth muscle cells, as in
                prior reports<sup>
<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R35">35</xref>
</sup>. Overall, the cell type identities, markers, and proportions match prior
                snRNA-seq data from adult human cortex (<xref ref-type="fig" rid="F7">Extended Data
                    Fig. 1</xref>-<xref ref-type="fig" rid="F10">4</xref>, <xref ref-type="supplementary-material" rid="SD2">Extended Data Table 2</xref>)<sup>
<xref ref-type="bibr" rid="R31">31</xref>–<xref ref-type="bibr" rid="R34">34</xref>
</sup>.</p>
<p id="P7">We compared levels of gene expression in cells isolated from COVID-19 versus
                non-viral control individuals by cell type and identified 2,194 unique
                differentially expressed genes (DEGs) that implicated all major cell types (<xref ref-type="supplementary-material" rid="SD3">Extended Data Table 3</xref>). As
                recently reported in Alzheimer's disease (AD)<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup>, neurons exhibited a strong signature of repression—73% of DEGs in excitatory
                neurons and 65% in interneurons were downregulated—whereas DEGs in glial
                oligodendrocytes, OPCs, astrocytes, and microglia were more balanced (36-51%, <xref ref-type="fig" rid="F1">Fig. 1c-d</xref>). The number of DEGs was greatest for
                astrocytes, excitatory neurons, and oligodendrocytes, partially reflecting increased
                power in these higher-abundance cell types. The vast majority of DEGs were perturbed
                in only a single cell type (∼84%, <xref ref-type="fig" rid="F1">Fig. 1e-f</xref>,
                    <xref ref-type="fig" rid="F11">Extended Data Fig. 5a</xref>), further indicating
                a cell type-specific CNS response to COVID-19. However, the minority of shared DEGs
                clustered into meaningful pathways: for example, commonly downregulated DEGs
                implicated impairments in brain-derived neurotrophic factor (BDNF) and interleukin-2
                (IL-2) signaling (<xref ref-type="fig" rid="F1">Fig. 1f</xref>), both critical for
                homeostatic neuronal function<sup>
<xref ref-type="bibr" rid="R36">36</xref>–<xref ref-type="bibr" rid="R40">40</xref>
</sup>. Overall, these results indicate that all major brain parenchymal cell types
                are affected at the transcriptional level by COVID-19, and that single-cell-level
                resolution is critical because changes in gene expression— including
                directionality—are dependent on cell type.</p>
</sec>
<sec id="S2">
<title>SARS-CoV-2 accumulation in barrier cells stimulates inflammatory signaling to the
                brain</title>
<p id="P8">The observed transcriptional response to COVID-19 in the brain could arise
                from direct neurotropism or indirect damage via peripheral inflammation<sup>
<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R16">16</xref>
</sup>. We thus stained for the SARS-CoV-2 spike glycoprotein<sup>
<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R41">41</xref>
</sup> in medial frontal cortex and choroid plexus tissue immediately adjacent to
                tissue used in snRNA-seq. Intriguingly, we detected spike glycoprotein robustly in
                two COVID-19 patients (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Upon closer
                examination however, spike glycoprotein signal resided only within the
                barrier-forming cortical vasculature, meninges, and choroid plexus. Within the
                choroid plexus, signal appeared within the stromal compartment, though confident
                cell type assignment was not possible (<xref ref-type="fig" rid="F2">Fig.
                2c</xref>). Thus, unlike recent reports where SARS-CoV-2 was added directly to
                neuroglial organoids lacking brain-barrier cells<sup>
<xref ref-type="bibr" rid="R21">21</xref>–<xref ref-type="bibr" rid="R25">25</xref>
</sup>, we do not observe significant virus invasion in cortex parenchymal cells. On
                the other hand, SARS-CoV-2 infection of the CSF-barrier forming choroid plexus and
                meninges corroborates recent <italic>in vitro</italic>, <italic>in silico</italic>,
                CSF, and postmortem case studies suggesting CNS barrier cells can support productive
                infection at relatively low titers<sup>
<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R42">42</xref>,<xref ref-type="bibr" rid="R43">43</xref>
</sup>. We note however that this absence of detectable SARS-CoV-2 neuroinvasion
                does not exclude its possibility. Likewise, it is possible that the other two
                COVID-19 patients sustain SARS-CoV-2 barrier cell infection undetected in the tissue
                sampled. Corroborating a recent study<sup>
<xref ref-type="bibr" rid="R5">5</xref>
</sup>, presence of SARS-CoV-2 in the CNS did not correlate with neurological
                symptoms (<xref ref-type="supplementary-material" rid="SD1">Extended Data Table
                    1</xref>). Together, these results suggest that brain-barrier cells may be
                particularly susceptible to SARS-CoV-2 infection, and that preferential accumulation
                of virus in the barriers may give rise to widespread cortical DEGs.</p>
<p id="P9">Because we detected SARS-CoV-2 spike glycoprotein in the blood-brain and
                blood-CSF-barrier cells, we sought to devise methods to profile these cells and
                better understand their relation to cortical transcriptional perturbations with
                COVID-19. However, conventional brain snRNA-seq preparation methods nearly
                universally deplete high-quality brain vascular nuclei from endothelial cells,
                pericytes, smooth muscle cells, and fibroblasts for currently unknown reasons<sup>
<xref ref-type="bibr" rid="R32">32</xref>–<xref ref-type="bibr" rid="R35">35</xref>
</sup>. At the same time, no snRNA-seq study exists on the human choroid plexus, in
                health or disease. This could, as we discovered, be because enzymatic and dounce
                homogenization techniques successfully used to process mouse tissue<sup>
<xref ref-type="bibr" rid="R29">29</xref>
</sup> resulted in a near complete loss of genes in isolated human choroid nuclei.
                We thus generated a method involving successive gentle triturations in mild
                detergent (Methods), yielding 24,052 nuclei across 7 major epithelial, mesenchymal,
                immune, and glial cell types (6 non-viral, 4 COVID-19, 1 influenza; <xref ref-type="fig" rid="F3">Fig. 3a</xref>, <xref ref-type="fig" rid="F10">Extended
                    Data Fig. 4</xref>, <xref ref-type="supplementary-material" rid="SD4">Extended
                    Data Table 4</xref>).</p>
<p id="P10">Epithelial cells accounted for 81% of choroid nuclei profiled, and
                interestingly, subclustered based on expression of the receptor (PRLR) for
                prolactin—a hormone mediating neurogenesis<sup>
<xref ref-type="bibr" rid="R44">44</xref>,<xref ref-type="bibr" rid="R45">45</xref>
</sup>—, the glutathione peroxidase GPX3—which protects the CSF from hydroperoxides<sup>
<xref ref-type="bibr" rid="R46">46</xref>
</sup>—, and the chloride anion exchanger SLC26A3—which may maintain physiologic ion
                concentrations in the CSF<sup>
<xref ref-type="bibr" rid="R47">47</xref>
</sup>. Similar to brain vascular cells<sup>
<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R48">48</xref>
</sup>, the choroid barrier and stromal epithelial, endothelial, mesenchymal, and
                ependymal cells robustly expressed the antiviral defense gene
                    <italic>IFITM3.</italic> Intriguingly, we observed a broad upregulation of
                    <italic>IFITM3</italic> across barrier cells in COVID-19 patients, consistent
                with immunohistochemical detection of SARS-CoV-2 infection (<xref ref-type="fig" rid="F3">Fig. 3b</xref>). <italic>IFITM3</italic> serves as the first line of
                defense against viral infection<sup>
<xref ref-type="bibr" rid="R49">49</xref>
</sup> and its upregulation is a marker of SARS-CoV-2 infection across publicly
                available datasets<sup>
<xref ref-type="bibr" rid="R50">50</xref>
</sup>. We also observed in the cortex parenchyma a consistent upregulation of the
                newly described viral entry receptor <italic>NRP1</italic>
                <sup>
<xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R51">51</xref>,<xref ref-type="bibr" rid="R52">52</xref>
</sup> (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, <xref ref-type="fig" rid="F12">Extended Data Fig. 6</xref>), which has been previously found upregulated in
                inflamed COVID-19 lung tissue<sup>
<xref ref-type="bibr" rid="R51">51</xref>,<xref ref-type="bibr" rid="R53">53</xref>
</sup>.</p>
<p id="P11">Overall, the DEGs detected in choroid epithelial cells, mesenchymal cells,
                and monocytes indicate strong CNS inflammation in COVID-19 (<xref ref-type="fig" rid="F3">Fig. 3c-e</xref>, <xref ref-type="supplementary-material" rid="SD5">Extended Data Table 5</xref>). For example, we observed upregulation of the
                pro-inflammatory cytokine IL-1β, which has been reported sufficient to induce
                pathologic microglial and astrocyte activation<sup>
<xref ref-type="bibr" rid="R54">54</xref>,<xref ref-type="bibr" rid="R55">55</xref>
</sup>. The coincident upregulation of <italic>IL-1β, CCL2,</italic> and
                    <italic>CCL4</italic> further suggests a weakened choroid barrier and an
                increasingly permissive environment for immune cell transmigration into the brain parenchyma<sup>
<xref ref-type="bibr" rid="R56">56</xref>–<xref ref-type="bibr" rid="R58">58</xref>
</sup>. The aged choroid plexus has recently been reported to send inflammatory
                signals to the brain, thereby activating glia and impairing cognitive function<sup>
<xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R60">60</xref>
</sup>. To assess if similar pro-inflammatory signaling mechanisms occur in
                COVID-19, we performed cell-cell communication analysis<sup>
<xref ref-type="bibr" rid="R61">61</xref>,<xref ref-type="bibr" rid="R62">62</xref>
</sup>. We observed a strong increase in choroid-to-cortex signaling across key
                inflammatory pathways, such as the CCL and CXCL family of chemokines (<xref ref-type="fig" rid="F3">Fig. 3f</xref>, <xref ref-type="fig" rid="F11">Extended
                    Data Fig. 5b</xref>). Together, these results suggest that SARS-CoV-2 can infect
                and inflame brain-barrier cells, including the choroid plexus; and that this
                barrier—together with peripheral—inflammation is then relayed into the brain
                parenchyma.</p>
</sec>
<sec id="S3">
<title>Immune cell infiltration and activation of neuronal engulfment programs in
                microglia</title>
<p id="P12">We sought to evaluate the predicted activation of brain microglia and
                migration of peripheral immune cells via enhanced inflammatory signaling from the
                periphery and brain-barrier cells. Intriguingly, we observed in the cortex a
                COVID-19 enriched subpopulation of microglia (<xref ref-type="fig" rid="F4">Fig.
                    4a-b</xref>, <xref ref-type="fig" rid="F13">Extended Data Fig. 7</xref>–<xref ref-type="fig" rid="F14">8</xref>). This cluster was marked by expression of
                genes implicated in human microglial activation, such as <italic>CD74</italic>,
                    <italic>FTL</italic>, and <italic>FTH1</italic> (<xref ref-type="supplementary-material" rid="SD6">Extended Data Table 6</xref>). These
                very genes have recently been described as difficult to detect by snRNA-seq<sup>
<xref ref-type="bibr" rid="R63">63</xref>
</sup>, further underscoring strong COVID-19 microglial activation. An
                over-represented fraction of COVID-19 microglia cluster marker genes overlap
                    (<italic>P &lt;</italic> 10<sup>−25</sup>, hypergeometric test) with human
                Alzheimer's disease microglia cluster markers<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup> (<xref ref-type="fig" rid="F13">Extended Data Fig. 7c</xref>). Monocle
                trajectory analysis<sup>
<xref ref-type="bibr" rid="R64">64</xref>
</sup> found that the COVID-19 microglia cluster emerged from the parent homeostatic
                population—and that the expression of activation markers increased along the
                pseudotime route—, suggesting that these microglia emerged in response to an
                increasingly inflamed CNS environment (<xref ref-type="fig" rid="F4">Fig. 4c</xref>,
                    <xref ref-type="fig" rid="F13">Extended Data Fig. 7a-b</xref>), consistent with
                enhanced brain-barrier inflammatory signaling. Our observations suggest that the
                COVID-19 subpopulation represents a distinct microglial state that shares features
                with, but is ultimately different from, microglial cell states previously reported
                in human neurodegenerative disease.</p>
<p id="P13">We next assessed the predicted increase in peripheral immune cell
                infiltration. We indeed found both an increase in T-cells (marked by
                    <italic>CD247</italic> encoding the TCR CD3-zeta protein, <xref ref-type="fig" rid="F4">Fig. 4d</xref>, <xref ref-type="fig" rid="F14">Extended Data Fig.
                    8e</xref>) and an increase in peripheral macrophages (marked by
                    <italic>F13A1</italic>
                <sup>
<xref ref-type="bibr" rid="R65">65</xref>,<xref ref-type="bibr" rid="R66">66</xref>
</sup>, <xref ref-type="fig" rid="F4">Fig. 4e</xref>). Microglial activation and
                enhanced immune cell infiltration have been recently reported by IHC staining in a
                series of 43 COVID-19 brains, with the degree of infiltration and glial activation
                not clearly correlated with neurological symptoms or the presence of detectable
                virus in the brain<sup>
<xref ref-type="bibr" rid="R5">5</xref>
</sup>. Our results largely corroborate those findings via an orthogonal snRNA-seq
                approach (<xref ref-type="fig" rid="F4">Fig. 4a-e</xref>). Both the formation of a
                distinct microglial cluster and the enhanced infiltration of peripheral T-cells and
                macrophages did not occur in terminal influenza, suggesting a COVID-19 specific—or
                at least not a pan-viral—CNS response.</p>
<p id="P14">Because we collected sufficient microglia for DEG analysis, we sought a
                clearer understanding of the functional ramifications of their COVID-19 activation.
                As expected, established markers of microglial activation previously linked to
                pathologic functions such as <italic>CD74</italic> and <italic>MERTK</italic> were
                strongly upregulated<sup>
<xref ref-type="bibr" rid="R67">67</xref>–<xref ref-type="bibr" rid="R74">74</xref>
</sup>. We observed a concomitant loss of the immune checkpoint molecules
                    <italic>MEF2C</italic> and <italic>IRAK3</italic> that restrain runaway inflammation<sup>
<xref ref-type="bibr" rid="R75">75</xref>–<xref ref-type="bibr" rid="R77">77</xref>
</sup>. Recently, increased microglial phagocytosis of live neurons—termed
                phagoptosis—has been demonstrated to be an important mechanism driving various
                neurodegenerative diseases<sup>
<xref ref-type="bibr" rid="R71">71</xref>,<xref ref-type="bibr" rid="R78">78</xref>–<xref ref-type="bibr" rid="R81">81</xref>
</sup>. Remarkably, nearly every gene reported<sup>
<xref ref-type="bibr" rid="R81">81</xref>
</sup> to mediate microglial phagocytosis of live neurons is strongly upregulated in
                COVID-19 microglia (<xref ref-type="fig" rid="F4">Fig. 4g</xref>). These include the
                genes encoding complement proteins C3, all three components of C1Q, and the
                pro-phagocytic receptors MERTK and VNR. Together, these data reveal in the COVID-19
                brain the infiltration of immune cells and strong activation of a pathologic
                microglial phagocytosis program predicted to prematurely engulf and prune live
                neurons.</p>
</sec>
<sec id="S4">
<title>Potential synaptic dysfunction specifically in layer 2/3 excitatory
                neurons</title>
<p id="P15">The global induction of microglial phagoptosis programs prompted us to look
                into other potential signatures of neuronal compromise. Astrocytes play a dual role
                in both forming the glia limitans barrier<sup>
<xref ref-type="bibr" rid="R82">82</xref>,<xref ref-type="bibr" rid="R83">83</xref>
</sup> and supporting homeostatic neuronal function<sup>
<xref ref-type="bibr" rid="R84">84</xref>–<xref ref-type="bibr" rid="R86">86</xref>
</sup> (<xref ref-type="fig" rid="F5">Fig. 5a</xref>). Given SARS-CoV-2 infection of
                barrier cells, we thus wondered whether astrocytes would exhibit similar hallmarks
                of inflammation with concomitant consequences for neuronal health. We indeed
                observed hallmarks of astrogliosis<sup>
<xref ref-type="bibr" rid="R87">87</xref>
</sup> and viral defense<sup>
<xref ref-type="bibr" rid="R50">50</xref>
</sup> in upregulated <italic>GFAP</italic> and <italic>IFITM3</italic> expression,
                as well as neurotoxicity in the secreted factor CHI3L1<sup>
<xref ref-type="bibr" rid="R88">88</xref>–<xref ref-type="bibr" rid="R90">90</xref>
</sup> (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, <xref ref-type="fig" rid="F5">Fig. 5a-d</xref>). Forming a tripartite synapse with neurons, astrocytes finely
                balance the levels of synaptic neurotransmitters like glutamate via the dedicated
                transporters EEAT1 (<italic>SLC1A3</italic>) and EEAT2 (<italic>SLC1A2</italic>)<sup>
<xref ref-type="bibr" rid="R91">91</xref>–<xref ref-type="bibr" rid="R93">93</xref>
</sup>. Dysregulated glutamate transporter expression causes neuronal dysfunction:
                downregulation results in excess glutamate excitotoxicity<sup>
<xref ref-type="bibr" rid="R94">94</xref>,<xref ref-type="bibr" rid="R95">95</xref>
</sup> and extrasynaptic spillover<sup>
<xref ref-type="bibr" rid="R96">96</xref>,<xref ref-type="bibr" rid="R97">97</xref>
</sup>; whereas upregulation impairs long-term potentiation (LTP) and synaptic plasticity<sup>
<xref ref-type="bibr" rid="R98">98</xref>–<xref ref-type="bibr" rid="R101">101</xref>
</sup>. We observed dysregulated overexpression of genes predicting diminished
                glutamate signaling across synapses: for example, the overexpression of both
                glutamate transporters (<italic>SLC1A2</italic> and <italic>SLC1A3</italic>, <xref ref-type="fig" rid="F5">Fig. 5a, e</xref>) as well as the major potassium uptake
                channel Kir4.1 (<italic>KCNJ10</italic>), which reduces neuronal excitability by
                lowering extracellular potassium, glutamate, and BDNF<sup>
<xref ref-type="bibr" rid="R102">102</xref>
</sup>.</p>
<p id="P16">We next sought to identify the neuronal subtypes affected in COVID-19.
                Enrichment analysis implicated potential impairments in synaptic transmission
                specifically in excitatory neurons (<xref ref-type="fig" rid="F15">Extended Data
                    Fig. 9</xref>). Among COVID-19 patients, those with objective neurological
                symptoms or detectable virus did not exhibit further deficits in the expression of
                genes mediating synaptic transmission (<xref ref-type="fig" rid="F15">Extended Data
                    Fig. 9c</xref>, <xref ref-type="supplementary-material" rid="SD1">Extended Data
                    Table 1</xref>). Glutamate release at synapses is critical for fast and faithful
                communication between neurons for information processing in sub-second timeframes<sup>
<xref ref-type="bibr" rid="R103">103</xref>–<xref ref-type="bibr" rid="R105">105</xref>
</sup>. Glutamate is stored in readily releasable pools of vesicles within
                presynaptic terminals. During synaptic transmission, SNARE proteins play an
                indispensable role in vesicle docking, priming, fusion, and synchronization of
                glutamate release into the synaptic cleft<sup>
<xref ref-type="bibr" rid="R103">103</xref>,<xref ref-type="bibr" rid="R104">104</xref>
</sup>. Downregulation of the mRNA encoding SNARE components has been found in
                various neurological diseases<sup>
<xref ref-type="bibr" rid="R106">106</xref>–<xref ref-type="bibr" rid="R109">109</xref>
</sup>, and is sufficient in experimental models to impair both vesicle processing
                and overall neuronal viability<sup>
<xref ref-type="bibr" rid="R110">110</xref>–<xref ref-type="bibr" rid="R114">114</xref>
</sup>. We observed in COVID-19 excitatory neurons a consistent downregulation of
                major SNARE components (<xref ref-type="fig" rid="F5">Fig. 5f</xref>). For example,
                genes encoding both v-SNARE synaptobrevins (<italic>VAMP1</italic>,
                    <italic>VAMP2</italic>) necessary for calcium-dependent glutamate release<sup>
<xref ref-type="bibr" rid="R115">115</xref>,<xref ref-type="bibr" rid="R116">116</xref>
</sup> decreased. Likewise, expression diminished for the partner t-SNARE proteins
                syntaxin 1B (<italic>STX1B</italic>) and SNAP-25, also necessary<sup>
<xref ref-type="bibr" rid="R117">117</xref>,<xref ref-type="bibr" rid="R118">118</xref>
</sup> for glutamate release.</p>
<p id="P17">The human neocortex is composed of six layers of interconnected excitatory
                and inhibitory neurons, with each layer both highly specialized locally and
                integrated globally. Of these six layers, layers 2 and 3 are disproportionately
                thickened during the evolution of the human brain, playing a key role in higher
                brain functions such as cognition, learning, memory, creativity, and abstraction<sup>
<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R119">119</xref>,<xref ref-type="bibr" rid="R120">120</xref>
</sup>. Though we captured neurons from all cortical layers, we found that gene
                expression changes linked to synaptic deficits are specific to only these layer 2/3
                excitatory neurons (<xref ref-type="fig" rid="F5">Fig. 5g</xref>). L2/3 excitatory
                neurons already exhibit sparse action potential firing to generate a simple and
                reliable neural code for associative learning<sup>
<xref ref-type="bibr" rid="R120">120</xref>
</sup>. Thus, this neuronal population may be particularly sensitive to the
                predicted deficits in neurotransmission with COVID-19. Together, these data suggest
                potential impairments in L2/3 neuron synaptic transmission, plasticity, and LTP in
                COVID-19, due to the dysregulation of genes mediating astrocyte glutamate
                homeostasis and genes encoding major synaptic vesicle components.</p>
</sec>
<sec id="S5">
<title>Associations with chronic CNS disease</title>
<p id="P18">Reports of lingering CNS complications in COVID-19 survivors are emerging<sup>
<xref ref-type="bibr" rid="R121">121</xref>
</sup>. To provide a molecular rationale for these complications, we compared
                COVID-19 cell type-specific DEGs with those recently described by snRNA-seq in
                chronic CNS diseases, including Alzheimer's disease<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup>, multiple sclerosis<sup>
<xref ref-type="bibr" rid="R122">122</xref>
</sup>, Huntington's disease<sup>
<xref ref-type="bibr" rid="R123">123</xref>
</sup>, and autism spectrum disorder<sup>
<xref ref-type="bibr" rid="R33">33</xref>
</sup>. Surprisingly, the overlap of DEGs between COVID-19 and these chronic CNS
                diseases was over-represented for each cell type (<xref ref-type="fig" rid="F6">Fig.
                    6a</xref>, <xref ref-type="fig" rid="F16">Extended Data Fig. 10</xref>, <xref ref-type="supplementary-material" rid="SD7">Extended Data Table 7</xref>). The
                degree of overlap was particularly high in astrocytes and excitatory neurons. For
                example, genes encoding the SNARE protein SNAP-25 and the neurotrophic factor BDNF
                were commonly downregulated in excitatory neurons in both COVID-19 and Alzheimer's disease<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup>. This over-representation of overlapping DEGs suggests existing CNS disease
                knowledge—and even treatment approaches—may be relevant to COVID-19
                neuropathology.</p>
<p id="P19">Genome-wide association studies (GWAS) have shed insight into the molecular
                pathways involved in complex traits and diseases<sup>
<xref ref-type="bibr" rid="R124">124</xref>,<xref ref-type="bibr" rid="R125">125</xref>
</sup>. GWAS variants suggest an important role for a given gene through its loss or
                gain of function or expression. Thus, differential expression of GWAS genes in
                COVID-19 may signal a re-emergence of these trait and disease pathways<sup>
<xref ref-type="bibr" rid="R32">32</xref>
</sup>. To determine the enrichment of COVID-19 DEGs within genetic variants
                associated with complex traits and diseases in a cell type-specific fashion, we
                obtained GWAS summary statistics for neurological and psychiatric disorders and
                neurobehavior traits (<xref ref-type="supplementary-material" rid="SD8">Extended
                    Data Table 8</xref>)<sup>
<xref ref-type="bibr" rid="R125">125</xref>–<xref ref-type="bibr" rid="R127">127</xref>
</sup>. We found a strong enrichment of DEGs residing within GWAS hits of various
                disorders and traits, especially in cognition, schizophrenia, and depression (<xref ref-type="fig" rid="F6">Fig. 6b</xref>). These particular disorders have been
                associated with dysfunction in L2/3 neurons and astrocytes<sup>
<xref ref-type="bibr" rid="R128">128</xref>– <xref ref-type="bibr" rid="R135">135</xref>
</sup>. Together, these data suggest that COVID-19 may partially recapitulate
                established pathological processes in the brain and provide molecular hypotheses for
                emerging neurological complaints in COVID-19 survivors.</p>
</sec>
<sec id="S6" sec-type="discussion">
<title>Discussion</title>
<p id="P20">Recent snRNA-seq studies have elucidated the cell type-specific processes
                involved in several CNS diseases<sup>
<xref ref-type="bibr" rid="R32">32</xref>–<xref ref-type="bibr" rid="R35">35</xref>,<xref ref-type="bibr" rid="R122">122</xref>,<xref ref-type="bibr" rid="R123">123</xref>
</sup>. Here, by combining sequencing of 47,678 nuclei in both frontal cortex and
                choroid plexus along with IHC detection of SARS-CoV-2 in brain-barrier cells, we
                reveal several major neuropathological mechanisms in severe COVID-19. Based on gene
                expression patterns uncovered in this study, we propose a model where SARS-CoV-2
                infected brain-barrier cells can relay and permit inflammatory signaling into the
                cortex parenchyma. In this inflammatory milieu, peripheral immune cells infiltrate
                the brain, microglia activate neuronal phagocytosis programs, and astrocyte
                homeostatic properties become dysregulated. Microglial activation is sufficient to
                induce a COVID-19 specific subpopulation. Together, these perturbations may converge
                on impaired neuronal function, with L2/3 excitatory neurons in particular exhibiting
                a transcriptomic signature of compromised glutamate transmission and information processing<sup>
<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R119">119</xref>,<xref ref-type="bibr" rid="R120">120</xref>
</sup>.</p>
<p id="P21">There are, however, limitations to consider given the unique logistical
                circumstances of a pandemic. With most postmortem COVID-19 brain tissue immediately fixed<sup>
<xref ref-type="bibr" rid="R42">42</xref>
</sup> or not handled with snRNA-seq studies in mind for safety and regulatory
                reasons, there is a lack of the high-quality tissue necessary for such studies<sup>
<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref>
</sup>. This has precluded larger study cohorts that could be more representative of
                COVID-19 patients as a whole. For example, while we and a recent IHC-based study of
                43 patient brains<sup>
<xref ref-type="bibr" rid="R5">5</xref>
</sup> (the largest to date) do not find a clear correlation between detectable
                brain SARS-CoV-2 and glial inflammation or neurological symptoms, this may not be
                representative of all patients, especially those without pre-existing co-morbidities
                or who do not require ventilation<sup>
<xref ref-type="bibr" rid="R136">136</xref>
</sup>. Furthermore, the associations with chronic CNS disease may not be relevant
                in mild COVID-19 disease and may change over time in severe COVID-19 survivors.
                Long-term postmortem studies of survivors after the acute phase of disease are not
                currently possible to assess this. However, there is precedent for acute viral
                infections causing long-term inflammation and dysfunction predisposing
                neurodegenerative disease<sup>
<xref ref-type="bibr" rid="R137">137</xref>–<xref ref-type="bibr" rid="R140">140</xref>
</sup>.</p>
<p id="P22">Understanding the underlying mechanisms of how SARS-CoV-2 affects the brain
                may inform therapeutic approaches<sup>
<xref ref-type="bibr" rid="R121">121</xref>
</sup>. Most molecular studies to date on SARS-CoV-2 neurotropism have made powerful
                use of cultured organoids, though they have reached conflicting conclusions<sup>
<xref ref-type="bibr" rid="R21">21</xref>–<xref ref-type="bibr" rid="R26">26</xref>
</sup>. Here, in postmortem COVID-19 patient tissue, we find that the blood-brain
                and blood-CSF barrier cells typically lacking in organoid models are of high
                physiologic relevance in informing questions of neurotropism. By combining IHC with
                a new method to process human choroid plexi tissue for snRNA-seq, we propose that
                infection of brain-barrier cells can generate a depot of strong antiviral
                inflammation and compromise barrier function, combining to inflame the brain
                parenchyma. Such brain-barrier relay and permeability mechanisms have been found
                important in brain aging<sup>
<xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R141">141</xref>–<xref ref-type="bibr" rid="R144">144</xref>
</sup>. Thus, COVID-19's impact on the brain, like many of its other properties, may
                follow a nuanced—but potentially therapeutically targetable—mechanism of action. We
                propose that the development of new techniques to study human brain-barrier cells
                will further help elucidate disease processes in COVID-19 and beyond.</p>
<p id="P23">The scale of the COVID-19 pandemic means thousands of people may suffer
                neurological symptoms, with some facing lifelong problems as a result. Our results
                nominate COVID-19 pathologic processes in microglia, astrocytes, and neurons not
                seen in a patient suffering terminal influenza infection. The particular
                vulnerability of layer 2/3 excitatory neurons in COVID-19 provides a consistent
                molecular hypothesis for emerging neurological complaints, from “brain fog” to
                memory loss to difficulty concentrating<sup>
<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R145">145</xref>,<xref ref-type="bibr" rid="R146">146</xref>
</sup>. Several COVID-19 perturbations revealed here may be addressable with
                existing medications<sup>
<xref ref-type="bibr" rid="R147">147</xref>
</sup>. However, as is the case for recent human transcriptomic studies, additional
                research will be required to link the observed cell type-specific gene expression
                changes with neurological symptoms<sup>
<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R35">35</xref>,<xref ref-type="bibr" rid="R122">122</xref>,<xref ref-type="bibr" rid="R123">123</xref>
</sup>. Nevertheless, these studies have served as important resources for
                understanding the molecular and cellular basis of disease and for formulating new
                lines of investigation. In summary, this work sheds insight into and provides new
                opportunities to explore the acute and lasting neurological consequences of
                COVID-19.</p>
</sec>
<sec id="S7" sec-type="methods" specific-use="web-only">
<title>Methods</title>
<sec id="S8">
<title>Isolation of nuclei from frozen post-mortem medial frontal gyrus</title>
<p id="P24">Frozen medial frontal cortex tissue from post-mortem control and
                    COVID-19 patients were obtained from the Stanford/ VA/ NIA Aging Clinical
                    Research Center (ACRC) and the Saarland University Hospital Institute for
                    Neuropathology, with approval from local ethics committees. Group
                    characteristics are presented in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>. The protocol for the isolation of
                    nuclei was adapted from previous studies<sup>
<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R35">35</xref>,<xref ref-type="bibr" rid="R148">148</xref>,<xref ref-type="bibr" rid="R149">149</xref>
</sup>, and performed in a BSL2+ Biosafety Cabinet wearing PPE. All procedures
                    were carried out on ice or at 4°C. Briefly, 50 mg of postmortem brain tissue was
                    dounce homogenized in 2 ml of Nuclei EZ Prep Lysis Buffer (Sigma, NUC101) spiked
                    with 0.2 U μl<sup>−1</sup> RNase inhibitor (Takara, 2313A) and EDTA-free
                    Protease Inhibitor Cocktail (Roche, 11873580001) before incubating on ice for 5
                    min in a final volume of 5 ml. Homogenized tissue was filtered through a 100-μm
                    cell strainer (Falcon, 352360), mixed with an equal volume of 50% iodixanol
                    density gradient medium in PBS (OptiPrep, Sigma-Aldrich, D1556) to make a final
                    concentration of 25% iodixanol. 30% iodixanol was layered underneath the 25%
                    mixture. Similarly, 40% iodixanol was layered underneath the 30% iodixanol. In a
                    swinging-bucket centrifuge, nuclei were centrifuged for 20 min at 3,000 r.c.f.
                    After centrifugation, the nuclei were present at the interface of the 30% and
                    40% iodixanol solutions. Isolated nuclei were resuspended in 1% BSA with 0.2 U
                        μl<sup>−1</sup> RNase inhibitor, filtered twice through a 40 μm strainer
                    (Flowmi), and counted on an TC20 automated cell counter (Bio-Rad) after the
                    addition of Trypan Blue. We did not use statistical methods to pre-determine
                    sample sizes, but our sample sizes are similar to those reported in previous publications<sup>
<xref ref-type="bibr" rid="R30">30</xref>–<xref ref-type="bibr" rid="R32">32</xref>
</sup>.</p>
</sec>
<sec id="S9">
<title>Isolation of nuclei from frozen post-mortem choroid plexus</title>
<p id="P25">Frozen choroid plexus tissue was extracted from the lateral ventricles
                    of post-mortem tissue obtained from the Stanford University Pathology department
                    and the Saarland University Hospital Institute for Neuropathology, with approval
                    from local ethics committees. Group characteristics are presented in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>.
                    All procedures were carried out on ice or at 4°C, and in a BSL2+ Biosafety
                    Cabinet wearing PPE. Dounce homogenization or enzymatic dissociation
                    successfully used for mice choroid plexi<sup>
<xref ref-type="bibr" rid="R29">29</xref>
</sup> resulted in loss of nuclei integrity and low nuclei complexity (&lt;50
                    median genes/ nuclei). We hypothesized that like shaking an apple tree, gentle
                    pipetting of choroid plexi tissue in lysis buffer could liberate nuclei without
                    needing to physically disintegrate the fibrous choroid matrix—and thus avoid
                    collateral physical damage to nuclei. Specifically, 40 mg of choroid plexus
                    tissue was thawed in 250 μl of 1% BSA with 0.2 U μl<sup>−1</sup> RNase inhibitor
                    until the tissue settled. 5 ml of lysis buffer (10 mM Tris, 10 mM NaCl, 3 mM
                    MgCl2, 0.1% Nonidet P40 substitute (Roche/ Sigma, 11754599001), 0.2 U
                        μl<sup>−1</sup> RNase inhibitor, and protease inhibitor) was added and
                    tissue incubated on ice for 10 minutes with gentle swirling every 2 minutes. 5
                    ml of 1% BSA was added and the tissue triturated 10 times with a 5 ml
                    serological pipette. After centrifugation (500g, 5 min), pelleted nuclei were
                    resuspended in 1% BSA with 0.2 U μl<sup>−1</sup> RNase inhibitor; gently
                    triturated 10 times with a 1 ml regular-bore pipette tip; and filtered twice
                    through a 70 μm and then a 40 μm strainer (Flowmi). Debris was inspected on a
                    brightfield microscope and nuclei were counted on an TC20 automated cell counter
                    (Bio-Rad) after the addition of Trypan Blue.</p>
</sec>
<sec id="S10">
<title>Droplet-based snRNA-sequencing</title>
<p id="P26">For droplet-based snRNA-seq, libraries were prepared using the Chromium
                    Next GEM Single Cell 3? v3.1 according to the manufacturer's protocol (10x
                    Genomics), targeting 10,000 nuclei per sample after counting with a TC20
                    Automated Cell Counter (Bio-Rad). 13 cycles were applied to brain parenchyma
                    samples to generate cDNA, and 15 for choroid plexus samples. All samples
                    underwent 15-16 cycles for final library generation. Generated snRNA-seq
                    libraries were sequenced across two S4 lanes on a NovaSeq 6000 (150 cycles,
                    Novogene).</p>
</sec>
<sec id="S11">
<title>snRNA-seq quality control</title>
<p id="P27">Gene counts were obtained by aligning reads to the hg38 genome
                    (refdata-gex-GRCh38-2020-A) using CellRanger software (v.4.0.0) (10x Genomics).
                    To account for unspliced nuclear transcripts, reads mapping to pre-mRNA were
                    counted. As previously published, a cut-off value of 200 unique molecular
                    identifiers (UMIs) was used to select single nuclei for further analysis<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup>. As initial reference, the entire dataset was projected onto
                    two-dimensional space using Uniform Manifold Approximation and Projection (UMAP)
                    on the top 20 principal components<sup>
<xref ref-type="bibr" rid="R150">150</xref>
</sup>. Three approaches were combined for quality control: (1) ambient cell
                    free mRNA contamination was removed using SoupX<sup>
<xref ref-type="bibr" rid="R151">151</xref>
</sup> for each individual sample; (2) outliers with a high ratio of
                    mitochondrial (&gt;5%, &lt;200 features) relative to endogenous RNAs and
                    homotypic doublets (&gt; 5000 features) were removed in Seurat<sup>
<xref ref-type="bibr" rid="R152">152</xref>
</sup>; and (3) after scTransform normalization and integration, doublets and
                    multiplets were filtered out using DoubletFinder with subsequent manual
                    inspection and filtering based on cell type-specific marker genes<sup>
<xref ref-type="bibr" rid="R153">153</xref>
</sup>. Genes detected in fewer than 4 cells were excluded. After applying these
                    filtering steps, the dataset contained 47,678 high-quality nuclei.</p>
</sec>
<sec id="S12">
<title>Cell annotations</title>
<p id="P28">Seurat's Integration function was used to align data with default
                    settings. Genes were projected into principal component (PC) space using the
                    principal component analysis (RunPCA). The first 80 (for global object), 30
                    (choroid plexus), or 25 (specific cell types) dimensions were used as inputs
                    into Seurat's FindNeighbors, FindClusters (at 0.2 resolution) and RunUMAP
                    functions. Briefly, a shared-nearest-neighbor graph was constructed based on the
                    Euclidean distance metric in PC space, and cells were clustered using the
                    Louvain method. RunUMAP functions with default settings was used to calculate
                    2-dimensional UMAP coordinates and search for distinct cell populations.
                    Positive differential expression of each cluster against all other clusters
                    (MAST) was used to identify marker genes for each cluster<sup>
<xref ref-type="bibr" rid="R154">154</xref>
</sup>. We annotated cell-types using previously published marker genes<sup>
<xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R33">33</xref>–<xref ref-type="bibr" rid="R35">35</xref>
</sup>.</p>
</sec>
<sec id="S13">
<title>Differential gene expression and sub-cluster analysis</title>
<p id="P29">Differential gene expression of genes comparing controls, COVID-19, and
                    influenza samples— or comparing cell type sub-cluster markers—was done using the MAST<sup>
<xref ref-type="bibr" rid="R154">154</xref>
</sup> algorithm, which implements a two-part hurdle model. Seurat default Log
                    (fold change) &gt; 0.25 (absolute value), adjusted <italic>P</italic> value
                    (Bonferroni correction) &lt; 0.05, and expression in greater than 10% of cells
                    were required to consider a gene differentially expressed. Biological pathway
                    and gene ontology enrichment analysis was performed using Enrichr<sup>
<xref ref-type="bibr" rid="R155">155</xref>
</sup>, Metascape<sup>
<xref ref-type="bibr" rid="R156">156</xref>
</sup>, or GeneTrail 3<sup>
<xref ref-type="bibr" rid="R157">157</xref>
</sup> with input species set to <italic>Homo sapiens</italic>
                    <sup>
<xref ref-type="bibr" rid="R156">156</xref>
</sup> and using standard parameters. Docking, processing, and viral defense
                    genes relevant to SARS-CoV-2 were chosen based on Iadecola, et al<sup>
<xref ref-type="bibr" rid="R16">16</xref>
</sup>. To identify microglia sub-cluster markers, differential expression
                    analysis of cells grouped in each sub-cluster was performed against the
                    remaining cells within the given cell-type. Markers were defined based on the
                    MAST algorithm using only positive values with Log (fold change) &gt; 0.25
                    (absolute value), adjusted P value (Bonferroni correction) &lt; 0.01.
                    Enrichment/ over-representation of the overlap between markers defining the
                    COVID-19 microglia 2 cluster and the Mathys<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup> Alzheimer's disease Mic1 cluster followed the hypergeometric probability,
                    using the set of 17,926 protein-coding genes as background.</p>
</sec>
<sec id="S14">
<title>Monocle trajectory analysis</title>
<p id="P30">Monocle3 (v.0.2.1.) was used to generate the pseudotime trajectory
                    analysis in microglia<sup>
<xref ref-type="bibr" rid="R64">64</xref>
</sup>. Cells were re-clustered as above and used as input into Monocle to infer
                    cluster and lineage relationships within a given cell type. Specifically, UMAP
                    embeddings and cell sub-clusters generated from Seurat were converted to a
                        <italic>cell_data_set</italic> object using SeuratWrappers (v.0.2.0) and
                    then used as input to perform trajectory graph learning and pseudo-time
                    measurement through reversed graph embedding with Monocle.</p>
</sec>
<sec id="S15">
<title>Viral transcripts</title>
<p id="P31">To search for SARS-CoV-2 reads, raw fastq files were subjected to read
                    alignment via Viral-Track<sup>
<xref ref-type="bibr" rid="R158">158</xref>
</sup> or centrifuge<sup>
<xref ref-type="bibr" rid="R159">159</xref>
</sup> using the human (GRCh38) genome reference. For Viral-Track both a
                    collection of 12,163 consensus virus sequences from Virusite<sup>
<xref ref-type="bibr" rid="R160">160</xref>
</sup> (release 2020.3) and 17,133 curated SARS-CoV-2 genomes from NCBI
                    (downloaded on 29-09-2020) were used. For centrifuge, a preprocessed virus index
                    compiled by genexa containing among other viruses 138 SARS-CoV-2 genomes was
                    used. We also adopted a complementary approach<sup>
<xref ref-type="bibr" rid="R161">161</xref>
</sup> focusing on SARS-CoV-2 reads, whereby barcoded but unmapped BAM reads
                    were aligned using STAR to the SARS-CoV-2 reference genome, with a less
                    stringent mapping parameter (outFilterMatchNmin 25-30) than the original
                    Viral-Track pipeline.</p>
</sec>
<sec id="S16">
<title>Cell-cell communication</title>
<p id="P32">Cell-cell interactions based on the expression of known ligand-receptor
                    pairs in different cell types were inferred using CellChatDB<sup>
<xref ref-type="bibr" rid="R61">61</xref>
</sup> (v.0.02). To identify potential cell-cell communication networks
                    perturbed or induced in COVID-19 patient brains, we focused on differentially
                    expressed ligands in choroid plexus epithelium, microglia, and astrocytes; and
                    differentially expressed receptor pairs in excitatory and inhibitory neurons.
                    Briefly, we followed the official workflow and loaded the normalized counts into
                    CellChat and applied the preprocessing functions
                        <italic>identifyOverExpressedGenes</italic>,
                        <italic>identifyOverExpressedInteractions</italic>, and
                        <italic>projectData</italic> with standard parameters set. As database we
                    selected the <italic>Secreted Signaling</italic> pathways and used the
                    pre-compiled human Protein-Protein-Interactions as a priori network information.
                    For the main analyses the core functions <italic>computeCommunProb</italic>,
                        <italic>computeCommunProbPathway</italic>, and <italic>aggregateNet</italic>
                    were applied using standard parameters and fixed randomization seeds. Finally,
                    to determine the senders and receivers in the network the function
                        <italic>netAnalysis_signalingRole</italic> was applied on the
                        <italic>netP</italic> data slot.</p>
</sec>
<sec id="S17">
<title>GWAS</title>
<p id="P33">From the GWAS catalog<sup>
<xref ref-type="bibr" rid="R126">126</xref>
</sup>, we obtained GWAS risk genes for neurological disorders [Alzheimer's
                    disease (AD), amyotrophic lateral sclerosis (ALS), brain aging, multiple system
                    atrophy (MSA), multiple sclerosis (MS), Parkinson's disease (PD), and
                    narcolepsy], psychiatric disorders [Attention deficit hyperactivity disorder
                    (ADHD), autism, bipolar disorder, depression, psychosis, post-traumatic stress
                    disorder (PTSD), and schizophrenia], and neurobehavior traits [Anxiety,
                    suicidality, insomnia, neuroticism, risk behavior, intelligence, and cognitive
                    function]. We removed gene duplicates and GWAS loci either not reported or in
                    intergenic regions and used a <italic>P &lt;</italic> 9 × 10<sup>−6</sup> to
                    identify significant associations<sup>
<xref ref-type="bibr" rid="R32">32</xref>
</sup>. Then, since GWAS signals can point to multiple candidate genes within
                    the same locus, we focused on the ‘Reported Gene(s)’ (genes reported as
                    associated by the authors of each GWAS study). Disorders and traits exhibiting a
                    significant number of genes also perturbed in COVID-19 patients are highlighted.
                    Following gene symbol extraction, we curated the gene set by (1) removing
                    unknown or outdated gene names using the HGNChelper package (v.0.8.6), (2)
                    converting remaining Ensembl gene IDs to actual gene names using the packages
                    ensembldb (v.2.10.0) and EnsDb.Hsapiens.v86 (v.2.99.0), and (3) removing any
                    remaining duplicates. We then calculated the overlap between each set of GWAS
                    genes with the cell type-specific DEGs. Finally, a statistical enrichment of
                    each overlap against background was calculated using a hypergeometric test with
                    the total background size set equal to the number of unique RNAs mapped in our
                    data set (29,431).</p>
</sec>
<sec id="S18">
<title>Comparison of DEGs in chronic CNS disease</title>
<p id="P34">We compiled cell type-specific differentially expressed genes (DEGs)
                    reported in published datasets for Alzheimer's Disease (AD)<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup>, Autism spectrum disorder (ASD)<sup>
<xref ref-type="bibr" rid="R33">33</xref>
</sup>, Huntington's disease (HD)<sup>
<xref ref-type="bibr" rid="R123">123</xref>
</sup>, and Multiple sclerosis (MS)<sup>
<xref ref-type="bibr" rid="R122">122</xref>
</sup>. Lists of gene symbols were curated using the aforementioned approach.
                    COVID-19 DEGs that overlap with those found across the selected CNS diseases
                    were called shared, whereas those not previously reported were called unique to
                    COVID-19. Statistical significance calculations of over-representation in DEG
                    overlaps are based on cumulative hypergeometric <italic>P</italic> values
                    analogous to the procedure described above.</p>
</sec>
<sec id="S19">
<title>PVCA and PCA analysis</title>
<p id="P35">Briefly, to conduct the Principal Variance Component Analysis (PVCA), we
                    aggregated the SoupX corrected raw counts for each gene and each biological
                    sample using the <italic>aggregateData</italic> function of the muscat package
                    (v.1.2.1). The resulting matrix was normalized by dividing each feature of a
                    sample by the total counts from that sample, multiplied by a scaling factor of
                    100,000 and scaling the result using the function log(x+1). As variables we
                    considered the sample annotation fields “Sample-ID”, “Patient-ID”, “Sex”,
                    “Brain-region”, “Disease”, “ageBin”, and “nNucleiBin”. Since the number of
                    nuclei and age are numeric variables but PVCA is designed to support factors, we
                    assigned the values into ordered bins, more specifically, into five half-open
                    (left-closed) intervals of size 1,000 starting at 2,000 for the number of nuclei
                    and five similarly defined intervals of size 10 starting at 51 for the age. We
                    set the algorithm cut-off for the minimal variance out of the total variance
                    being explained to be 95%. For each single annotation variable, or first
                    higher-order combinations of such, at cut-off of 0.005 was applied to consider
                    them explanatory. All variables (or combinations of such) not passing the
                    threshold were summarized as <italic>Other</italic> in the analysis. The
                    residual is then defined as the remaining proportion of variance not being
                    associated with any of the variables that are explanatory nor informative to a
                    minor proportion. To conduct Principal Components Analysis (PCA) we aggregated
                    the log-normalized cell counts from Seurat for each gene and sample using the
                        <italic>aggregateData</italic> function from muscat and centered the gene
                    expression vectors before computing eigenvectors.</p>
</sec>
<sec id="S20">
<title>Overall in-silico analysis</title>
<p id="P36">Analysis and dissection of the data was performed using the statistical
                    programming language R (v.3.6.3) using the following general-purpose package for
                    loading, saving, and manipulating data, as well as generating plots, and fitting
                    statistical models: dplyr (v.1.0.0), ggplot2 (v.3.2.2.), patchwork (v.1.0.1),
                    openxlsx (v.4.1.5), bioconductor-scater (v.1.14.6), bioconductor-dropletutils
                    (v1.6.1), bioconductor-complexheatmap (v.2.2.0), tidyverse (v.1.3.0), and lsa
                    (v.0.73.2). All other tasks were performed on an x86_64-based Ubuntu
                    (4.15.0-55-generic kernel) server cluster.</p>
</sec>
<sec id="S21">
<title>Immunohistochemistry</title>
<p id="P37">Paraffin-embedded human brain tissue (medial frontal cortex, meninges,
                    and choroid plexus) adjacent to tissue processed for snRNA-seq was subjected to
                    immunohistochemistry (IHC). After deparaffinization and rehydration of 1-3 μm
                    sections, peroxidases were blocked by incubation in 1%
                        H<sub>2</sub>O<sub>2</sub> for 15 minutes at room temperature. Heat antigen
                    retrieval was performed by steaming at 98°C in target retrieval solution pH 6.1
                    (Dako, Carpinteira, CA, USA #S1699) for 30 minutes. Sections were allowed to
                    cool down at room temperature. Following antigen retrieval, sections were
                    incubated for 45 minutes at room temperature with the anti-SARS spike
                    glycoprotein antibody 3A2 (rabbit, Abcam ab272420 1:100 diluted in Dako REAL
                    antibody diluent #S2022), which has been validated in previous publications<sup>
<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R41">41</xref>
</sup>. After three washes with wash buffer (Dako #S3006), the Dako REAL
                    EnVision HRP kit (#K5007) was used for the visualization of the antibody
                    reaction according to the manufacturer's instructions. Sections were
                    counterstained with Mayer's hemalum (Sigma-Aldrich #1.09249). After dehydration,
                    coverslips were mounted with Entellan (Merck #1.07961). Images were acquired
                    with an Olympus BX 40 microscope, equipped with an Olympus SC30 digital
                    microscope camera using the Olympus cellSens software.</p>
</sec>
</sec>
<sec id="S22" sec-type="extended-data">
<title>Extended Data</title>
<fig id="F7" position="anchor">
<label>Extended Data Figure 1</label>
<caption>
<title>Characterization of human cortical and choroid plexi nuclei
                        sequenced.</title>
<p id="P38">
                        <bold>a</bold>, Total number of nuclei and median number of genes of each
                        human sample sequenced in medial frontal cortex and choroid plexus.</p>
<p id="P39">
                        <bold>b</bold>, Quantification of the median number of genes detected per
                        nuclei in controls (non-viral and influenza) and COVID-19 samples in medial
                        frontal cortex and choroid plexus (<italic>n</italic>=5-7 controls and
                            <italic>n</italic>=4 COVID-19,two-sided t-test; mean +/- s.e.m.).</p>
<p id="P40">
                        <bold>c</bold>, <bold>d</bold>, Bar graph presenting frequency of nuclei for
                        non-viral controls, influenza, and COVID-19 medial frontal cortex
                            (<bold>c</bold>) and choroid plexus (<bold>d</bold>) sample groups.</p>
</caption>
<graphic xlink:href="EMS100941-f007"/>
</fig>
<fig id="F8" position="anchor">
<label>Extended Data Figure 2</label>
<caption>
<title>Gene expression variance analysis.</title>
<p id="P41">
                        <bold>a</bold>, Principal variance component analysis, displaying the gene
                        expression variance explained by residuals (biological and technical noise)
                        or experimental factors such as brain region, age, sex, and
                        respective combinations. <italic>n</italic> = 15 samples.</p>
<p id="P42">
                        <bold>b</bold>, Principal component analysis (PCA) visualization of all
                        samples, based on unscaled counts.</p>
</caption>
<graphic xlink:href="EMS100941-f008"/>
</fig>
<fig id="F9" position="anchor">
<label>Extended Data Figure 3</label>
<caption>
<title>Markers for annotating parenchymal cells in the human frontal medial
                        cortex.</title>
<p id="P43">
                        <bold>a</bold>, Discovery of the top cell type-specific genes across the 12
                        classes of cells captured in the human cortex. The color bar indicates gene
                        expression from low (blue) to high (yellow).</p>
<p id="P44">
                        <bold>b</bold>, Validation of cell type annotations using established cell
                        type-specific markers. Violin plots are centered around the median, with
                        their shape representing cell distribution.</p>
</caption>
<graphic xlink:href="EMS100941-f009"/>
</fig>
<fig id="F10" position="anchor">
<label>Extended Data Figure 4</label>
<caption>
<title>Markers for annotating parenchymal cells in the human choroid
                        plexus.</title>
<p id="P45">Validation of cell type annotations using established cell
                        type-specific markers. Subsets of epithelial cells are marked by high
                        expression of specific markers not previously described in mice. Violin
                        plots are centered around the median, with their shape representing cell
                        distribution.</p>
</caption>
<graphic xlink:href="EMS100941-f010"/>
</fig>
<fig id="F11" position="anchor">
<label>Extended Data Figure 5</label>
<caption>
<title>Cell-type specific changes in gene expression and intercellular signaling
                        in the COVID-19 brain.</title>
<p id="P46">
                        <bold>a</bold>, Heatmap displaying the number of significant biological
                        pathways among the set of differentially expressed genes in each cell type
                        (FDR &lt; 0.05, Fisher's exact test with Benjamini-Hochberg correction).
                        Number of significant pathways is indicated in graded black (high) to yellow
                        (high).</p>
<p id="P47">
                        <bold>b</bold>, Circle plot showing the total inferred intercellular
                        signaling network, aggregating across the signaling molecule interaction
                        (i.e., ligand-receptor) CellChatDB database<sup>
<xref ref-type="bibr" rid="R61">61</xref>
</sup>.</p>
</caption>
<graphic xlink:href="EMS100941-f011"/>
</fig>
<fig id="F12" position="anchor">
<label>Extended Data Figure 6</label>
<caption>
<title>Expression of SARS-CoV-2 virus entry genes across cell types.</title>
<p id="P48">
                        <bold>a</bold>, <bold>b</bold>, Expression of SARS-CoV-2 entry receptors,
                        established and putative, across cell types in the human medial frontal
                        cortex (<bold>a</bold>) and choroid plexus (<bold>b</bold>). Violin plots
                        are centered around the median, with their shape representing cell
                        distribution.</p>
</caption>
<graphic xlink:href="EMS100941-f012"/>
</fig>
<fig id="F13" position="anchor">
<label>Extended Data Figure 7</label>
<caption>
<title>Evolution and properties of the COVID-19 enriched microglia
                        cluster.</title>
<p id="P49">
                        <bold>a</bold>, <bold>b</bold>, Expression of established microglia
                        activation markers (<bold>b</bold>) and SARS-CoV-2 entry receptors
                            (<bold>c</bold>) along the pseudotime route in (<bold>a</bold>).
                        Pseudotime is indicated in graded purple (high) to yellow (high).</p>
<p id="P50">
                        <bold>c</bold>, Overlap (hypergeometric test) between Alzheimer's disease
                        human activated microglia Mic1 marker genes<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup> and genes upregulated in the COVID-19 enriched Microglia 2
                        subcluster.</p>
<p id="P51">
                        <bold>d</bold>, Enriched biological pathways amongst Microglia 2 marker
                        genes. Enrichment is based on FDR-corrected cumulative hypergeometric
                            <italic>P</italic> values, with a <italic>P</italic> value-ranked
                        gene-marker list (FDR &lt; 0.01, log2(mean gene expression across Microglia
                        2/ mean gene expression across all microglia) &gt; 0.25, MAST).</p>
</caption>
<graphic xlink:href="EMS100941-f013"/>
</fig>
<fig id="F14" position="anchor">
<label>Extended Data Figure 8</label>
<caption>
<title>Evaluation of COVID-19 enriched subpopulations in other parenchymal
                        glia.</title>
<p id="P52">
                        <bold>a</bold>, UMAP projection of oligodendrocyte progenitor cells (OPCs,
                            <italic>n</italic> = 1,634 from 4 non-viral controls, 1 influenza and 4
                        COVID-19 individuals) and the emergence of COVID-19 enriched subcluster.</p>
<p id="P53">
                        <bold>b</bold>, Quantification of the frequency of the COVID-19 enriched OPC
                        subcluster as a proportion of all OPCs (<italic>n</italic>=5 controls and
                            <italic>n</italic>=4 COVID-19, two-sided t-test; mean +/- s.e.m.).</p>
<p id="P54">
                        <bold>c</bold>, <bold>d</bold>, As in (<bold>a</bold>-<bold>b</bold>) but
                        for oligodendrocytes.</p>
<p id="P55">
                        <bold>e</bold>, Expression of the established T-cell marker
                            <italic>CD247</italic> (encoding TCR CD3 zeta chain) among immune cells
                        captured in human medial frontal cortex.</p>
</caption>
<graphic xlink:href="EMS100941-f014"/>
</fig>
<fig id="F15" position="anchor">
<label>Extended Data Figure 9</label>
<caption>
<title>Processes downregulated in excitatory neurons in COVID-19.</title>
<p id="P56">
                        <bold>a</bold>, Enriched biological pathways amongst downregulated genes in
                        COVID-19 excitatory neurons (<italic>n</italic> =7,680 from 4 non-viral
                        controls, 1 influenza and 4 COVID-19 individuals). Enrichment is based on
                        FDR-corrected cumulative hypergeometric <italic>P</italic> values, with a
                            <italic>P</italic> value-ranked gene-marker list (Log (fold change)&gt;
                        0.25 (absolute value), adjusted <italic>P</italic> value (Bonferroni
                        correction) &lt; 0.05, MAST).</p>
<p id="P57">
                        <bold>b</bold>, As in (<bold>a</bold>) but for Gene Ontology cellular
                        components.</p>
<p id="P58">
                        <bold>c</bold>, As in (<bold>a</bold>) but comparing COVID-19 patients with
                        neurological symptoms versus those without.</p>
</caption>
<graphic xlink:href="EMS100941-f015"/>
</fig>
<fig id="F16" position="anchor">
<label>Extended Data Figure 10</label>
<caption>
<title>Comparison of cell type-specific changes in COVID-19 with chronic CNS
                        diseases.</title>
<p id="P59">Upset matrix plots comparing the cell type-specific genes expression
                        changes in COVID-19 frontal cortex with those previously published for
                        Alzheimer's Disease (AD)<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup>, Autism spectrum disorder (ASD)<sup>
<xref ref-type="bibr" rid="R33">33</xref>
</sup>, Huntington's disease (HD)<sup>
<xref ref-type="bibr" rid="R123">123</xref>
</sup>, and Multiple sclerosis (MS)<sup>
<xref ref-type="bibr" rid="R122">122</xref>
</sup>.</p>
</caption>
<graphic xlink:href="EMS100941-f016"/>
</fig>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>ED Table 1 Patient Information</label>
<media xlink:href="EMS100941-supplement-ED_Table_1_Patient_Information.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N68117" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>ED Table 2 Cortex Parenchyma Markers</label>
<media xlink:href="EMS100941-supplement-ED_Table_2_Cortex_Parenchyma_Markers.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N68126" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>ED Table 3 Cortex Parenchyma DEGs</label>
<media xlink:href="EMS100941-supplement-ED_Table_3_Cortex_Parenchyma_DEGs.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N68135" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<label>ED Table 4 Choroid Plexus Markers</label>
<media xlink:href="EMS100941-supplement-ED_Table_4_Choroid_Plexus_Markers.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N68144" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD5">
<label>ED Table 5 Choroid Plexus DEGs</label>
<media xlink:href="EMS100941-supplement-ED_Table_5_Choroid_Plexus_DEGs.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N68153" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD6">
<label>ED Table 6 Microglia COVID subcluster markers</label>
<media xlink:href="EMS100941-supplement-ED_Table_6_Microglia_COVID_subcluster_markers.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N68162" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD7">
<label>ED Table 7 DEG overlap CNS disease</label>
<media xlink:href="EMS100941-supplement-ED_Table_7_DEG_overlap_CNS_disease.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N68171" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD8">
<label>ED Table 8 CNS GWAS genes</label>
<media xlink:href="EMS100941-supplement-ED_Table_8_CNS_GWAS_genes.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N68180" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S23">
<title>Acknowledgments</title>
<p>We thank N. Khoury, T. Iram, E. Tapp, O. Hahn, and other members of the Wyss-Coray
                and Keller labs for feedback and support, and H. Zhang and K. Dickey for laboratory
                management. This work was funded by the NOMIS Foundation (T.W.-C.), the National
                Institute on Aging (T32-AG0047126 to A.C.Y., 1RF1AG059694 to T.W.-C), Nan Fung Life
                Sciences (T.W.-C.), the Bertarelli Brain Rejuvenation Sequencing Cluster (an
                initiative of the Stanford Wu Tsai Neurosciences Institute), and the Stanford
                Alzheimer's Disease Research Center (P30 AG066515). A.C.Y was supported by a Siebel
                Scholarship. F.K., G.S., T.F., W.S.-S., and A.K., are a part of the CORSAAR study
                supported by the State of Saarland, the Saarland University, and the Rolf M.
                Schwiete Stiftung.</p>
</ack>
<sec id="S24" sec-type="data-availability">
<title>Data availability</title>
<p id="P60">Raw sequencing data is deposited under NCBI GEO: GSE159812. Normalized
                counts data also available for download at: <ext-link ext-link-type="uri" xlink:href="https://twc-stanford.shinyapps.io/scRNA_Brain_COVID19">https://twc-stanford.shinyapps.io/scRNA_Brain_COVID19</ext-link>
            </p>
</sec>
<fn-group>
<fn id="FN1" fn-type="con">
<p id="P61">
                    <bold>Author contributions</bold>
                </p>
<p id="P62">A.C.Y., F.K., A.K. and T.W.-C. conceptualized the study. M.W.M., N.L.,
                    I.C., W.S.-S., N.S., D.C., D.B., and A.C.Y. provided and organized tissue
                    samples. A.C.Y. performed tissue dissociations. A.C.Y., N.S., D.P.L., R.T.V.,
                    D.G., and K.C. prepared libraries for sequencing. F.K., G.S., T.F., and A.C.Y.
                    performed computational analysis, with F.K. leading advanced analysis and data
                    management. P.M.L. developed the searchable web interface (Shiny app). W.S.-S.
                    performed immunohistochemical stains. A.C.Y. and C.A.M. assembled figures.
                    A.C.Y. wrote the manuscript with input from all authors. T.W.-C. and A.K.
                    supervised the study.</p>
</fn>
<fn fn-type="conflict" id="FN2">
<p id="P63">
                    <bold>Competing interests</bold>
                </p>
<p id="P64">T.W.-C. is a founder and scientific advisor of Alkahest Inc.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Neurologic Manifestations of Hospitalized Patients with
                        Coronavirus Disease 2019 in Wuhan, China</article-title>
<source>JAMA Neurol</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1001/jamaneurol.2020.1127</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>
<article-title>Clinical course and outcomes of critically ill patients with
                        SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective,
                        observational study</article-title>
<source>Lancet Respir Med</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30079-5</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helms</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Neurologic features in severe SARS-COV-2
                        infection</article-title>
<source>New England Journal of Medicine</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1056/NEJMc2008597</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gidon</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Dendritic action potentials and computation in human layer 2/3
                        cortical neurons</article-title>
<source>Science (80-)</source>
<year>2020</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1126/science.aax6239</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matschke</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Neuropathology of patients with COVID-19 in Germany: a
                        post-mortem case series</article-title>
<source>Lancet Neurol</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varatharaj</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Neurological and neuropsychiatric complications of COVID-19 in
                        153 patients: a UK-wide surveillance study</article-title>
<source>The Lancet Psychiatry</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/S2215-0366(20)30287-X</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montalvan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bueso</surname>
<given-names>T</given-names>
</name>
<name>
<surname>De Toledo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rivas</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Neurological manifestations of COVID-19 and other coronavirus
                        infections: A systematic review</article-title>
<source>Clinical Neurology and Neurosurgery</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.clineuro.2020.105921</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Nervous system involvement after infection with COVID-19 and
                        other coronaviruses</article-title>
<source>Brain, Behavior, and Immunity</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.bbi.2020.03.031</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bialek</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Severe Outcomes Among Patients with Coronavirus Disease 2019
                        (COVID-19) - United States, February 12-March 16, 2020</article-title>
<source>MMWR Morb Mortal Wkly Rep</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.15585/mmwr.mm6912e2</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero-Sánchez</surname>
<given-names>CM</given-names>
</name>
<etal/>
</person-group>
<article-title>Neurologic manifestations in hospitalized patients with COVID-19:
                        The ALBACOVID registry</article-title>
<source>Neurology</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000009937</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liotta</surname>
<given-names>EM</given-names>
</name>
<etal/>
</person-group>
<article-title>Frequent neurologic manifestations and encephalopathy-associated
                        morbidity in Covid-19 patients</article-title>
<source>Ann Clin Transl Neurol</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>JP</given-names>
</name>
<etal/>
</person-group>
<article-title>Psychiatric and neuropsychiatric presentations associated with
                        severe coronavirus infections: a systematic review and meta-analysis with
                        comparison to the COVID-19 pandemic</article-title>
<source>The Lancet Psychiatry</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/S2215-0366(20)30203-0</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>SKW</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Tsang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>KC</given-names>
</name>
</person-group>
<article-title>Psychological distress and negative appraisals in survivors of
                        severe acute respiratory syndrome (SARS)</article-title>
<source>Psychol Med</source>
<year>2004</year>
<pub-id pub-id-type="doi">10.1017/S0033291704002272</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>MHB</given-names>
</name>
<etal/>
</person-group>
<article-title>Mental morbidities and chronic fatigue in severe acute
                        respiratory syndrome survivors long-term follow-up</article-title>
<source>Arch Intern Med</source>
<year>2009</year>
<pub-id pub-id-type="doi">10.1001/archinternmed.2009.384</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellul</surname>
<given-names>MA</given-names>
</name>
<etal/>
</person-group>
<article-title>Neurological associations of COVID-19</article-title>
<source>The Lancet Neurology</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/S1474-4422(20)30221-0</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iadecola</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Anrather</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kamel</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Effects of COVID-19 on the Nervous System</article-title>
<source>Cell</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.08.028</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puelles</surname>
<given-names>VG</given-names>
</name>
<etal/>
</person-group>
<article-title>Multiorgan and Renal Tropism of SARS-CoV-2</article-title>
<source>The New England journal of medicine</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1056/NEJMc2011400</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solomon</surname>
<given-names>IH</given-names>
</name>
<etal/>
</person-group>
<article-title>Neuropathological Features of Covid-19</article-title>
<source>The New England journal of medicine</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1056/NEJMc2019373</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moriguchi</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>A first case of meningitis/encephalitis associated with
                        SARS-Coronavirus-2</article-title>
<source>Int J Infect Dis</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.ijid.2020.03.062</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meinhardt</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Olfactory transmucosal SARS-CoV-2 invasion as port of Central
                        Nervous System entry in COVID-19 patients</article-title>
<source>bioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>Neuroinvasive potential of SARS-CoV-2 revealed in a human brain
                        organoid model</article-title>
<source>bioRxiv</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.06.25.169946</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramani</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 targets cortical neurons of 3D human brain organoids
                        and shows neurodegeneration-like effects</article-title>
<source>bioRxiv (Preprint)</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.05.20.106575</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pellegrini</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 infects brain choroid plexus and disrupts the
                        blood-CSF-barrier</article-title>
<source>bioRxiv</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.08.20.259937</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacob</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Human Pluripotent Stem Cell-Derived Neural Cells and Brain
                        Organoids Reveal SARS-CoV-2 Neurotropism</article-title>
<source>bioRxiv</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.07.28.225151</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>BZ</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 infects human neural progenitor cells and brain
                        organoids</article-title>
<source>Cell Research</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1038/s41422-020-0390-x</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mesci</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<source>Sofosbuvir protects human brain organoids against SARS-CoV-2</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.05.30.125856</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhaduri</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Cell stress in cortical organoids impairs molecular subtype
                        specification</article-title>
<source>Nature</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1038/s41586-020-1962-0</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Knoblich</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Lutolf</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Martinez-Arias</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The hope and the hype of organoid research</article-title>
<source>Dev</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.1242/dev.150201</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dani</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>A cellular and spatial map of the choroid plexus across brain
                        ventricles and ages</article-title>
<source>bioRxiv</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1101/627539</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>A single-cell RNA-seq survey of the developmental landscape of
                        the human prefrontal cortex</article-title>
<source>Nature</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1038/nature25980</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lake</surname>
<given-names>BB</given-names>
</name>
<etal/>
</person-group>
<article-title>Integrative single-cell analysis of transcriptional and
                        epigenetic states in the human adult brain</article-title>
<source>Nat Biotechnol</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1038/nbt.4038</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grubman</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>A single-cell atlas of entorhinal cortex from individuals with
                        Alzheimer's disease reveals cell-type-specific gene expression
                        regulation</article-title>
<source>Nat Neurosci</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1038/s41593-019-0539-4</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velmeshev</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-cell genomics identifies cell type-specific molecular
                        changes in autism</article-title>
<source>Science (80-)</source>
<year>2019</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1126/science.aav8130</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathys</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-cell transcriptomic analysis of Alzheimer's
                        disease</article-title>
<source>Nature</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1038/s41586-019-1195-2</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Human and mouse single-nucleus transcriptomics reveal
                        TREM2-dependent and TREM2-independent cellular responses in Alzheimer's
                        disease</article-title>
<source>Nat Med</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1038/s41591-019-0695-9</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen-Cory</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kidane</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Shirkey</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Marshak</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor and the development of
                        structural neuronal connectivity</article-title>
<source>Developmental Neurobiology</source>
<year>2010</year>
<pub-id pub-id-type="doi">10.1002/dneu.20774</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bathina</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>UN</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor and its clinical
                        Implications</article-title>
<source>Archives of Medical Science</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.5114/aoms.2015.56342</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prinz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van Rossum</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hanisch</surname>
<given-names>UK</given-names>
</name>
</person-group>
<article-title>Interleukin-2 as a Neuroregulatory Cytokine</article-title>
<source>NeuroImmune Biology</source>
<year>2008</year>
<pub-id pub-id-type="doi">10.1016/S1567-7443(07)10008-9</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarder</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Interleukin-2 promotes survival and neurite extension of cultured
                        neurons from fetal rat brain</article-title>
<source>Brain Res</source>
<year>1993</year>
<pub-id pub-id-type="doi">10.1016/0006-8993(93)91080-C</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Awatsuji</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Interleukin-2 as a neurotrophic factor for supporting the
                        survival of neurons cultured from various regions of fetal rat
                        brain</article-title>
<source>J Neurosci Res</source>
<year>1993</year>
<pub-id pub-id-type="doi">10.1002/jnr.490350310</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cantuti-Castelvetri</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<source>Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible
                        pathway into the central nervous system</source>
<year>2020</year>
<fpage>1</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1101/2020.06.07.137802</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryce</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Pathophysiology of SARS-CoV-2: targeting of endothelial cells
                        renders a complex disease with thrombotic microangiopathy and aberrant
                        immune response. The Mount Sinai COVID-19 autopsy experience</article-title>
<source>medRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2
                        - implications for microvascular inflammation and hypercoagulopathy in
                        COVID-19 patients</article-title>
<source>bioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shingo</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Pregnancy-stimulated neurogenesis in the adult female forebrain
                        mediated by prolactin</article-title>
<source>Science (80-)</source>
<year>2003</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1126/science.1076647</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larsen</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Grattan</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Prolactin, neurogenesis, and maternal behaviors</article-title>
<source>Brain, Behavior, and Immunity</source>
<year>2012</year>
<pub-id pub-id-type="doi">10.1016/j.bbi.2011.07.233</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saudrais</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Strazielle</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ghersi-Egea</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Choroid plexus glutathione peroxidases are instrumental in
                        protecting the brain fluid environment from hydroperoxides during postnatal
                        development</article-title>
<source>Am J Physiol - Cell Physiol</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1152/ajpcell.00094.2018</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname>
<given-names>NR</given-names>
</name>
<etal/>
</person-group>
<article-title>Influx mechanisms in the embryonic and adult rat choroid plexus:
                        A transcriptome study</article-title>
<source>Front Neurosci</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.3389/fnins.2015.00123</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodge</surname>
<given-names>RD</given-names>
</name>
<etal/>
</person-group>
<article-title>Conserved cell types with divergent features in human versus
                        mouse cortex</article-title>
<source>Nature</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1038/s41586-019-1506-7</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailey</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Farzan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>IFITM-family proteins: The cell's first line of antiviral
                        defense</article-title>
<source>Annu Rev Virol</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.1146/annurev-virology-031413-085537</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hachim</surname>
<given-names>MY</given-names>
</name>
<etal/>
</person-group>
<article-title>Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated
                        Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells</article-title>
<source>Front Immunol</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.01372</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daly</surname>
<given-names>JL</given-names>
</name>
<etal/>
</person-group>
<article-title>Neuropilin-1 is a host factor for SARS-CoV-2
                        infection</article-title>
<source>bioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moutal</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor
                        signaling to induce analgesia</article-title>
<source>Pain</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1097/j.pain.0000000000002097</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ackermann</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Pulmonary vascular endothelialitis, thrombosis, and angiogenesis
                        in Covid-19</article-title>
<source>N Engl J Med</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1056/NEJMoa2015432</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaftel</surname>
<given-names>SS</given-names>
</name>
<etal/>
</person-group>
<article-title>Sustained hippocampal IL-1β overexpression mediates chronic
                        neuroinflammation and ameliorates Alzheimer plaque pathology</article-title>
<source>J Clin Invest</source>
<year>2007</year>
<pub-id pub-id-type="doi">10.1172/JCI31450</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaftel</surname>
<given-names>SS</given-names>
</name>
<etal/>
</person-group>
<article-title>Chronic interleukin-1β expression in mouse brain leads to
                        leukocyte infiltration and neutrophil-independent blood-brain barrier
                        permeability without overt neurodegeneration</article-title>
<source>J Neurosci</source>
<year>2007</year>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1418-07.2007</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahad</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Modulating CCR2 and CCL2 at the blood-brain barrier: Relevance
                        for multiple sclerosis pathogenesis</article-title>
<source>Brain</source>
<year>2006</year>
<pub-id pub-id-type="doi">10.1093/brain/awh655</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guedes</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Lao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>El Khoury</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Roles of microglial and monocyte chemokines and their receptors
                        in regulating Alzheimer's disease-associated amyloid-β and tau
                        pathologies</article-title>
<source>Frontiers in Neurology</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.3389/fneur.2018.00549</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Inflammation of the embryonic blood-cerebrospinal fluid barrier
                        following maternal immune activation</article-title>
<source>Submitt to Dev Cell</source>
<year>2020</year>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/j.devcel.2020.09.020</pub-id>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baruch</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Aging-induced type I interferon response at the choroid plexus
                        negatively affects brain function</article-title>
<source>Science (80-)</source>
<year>2014</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1126/science.1252945</pub-id>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baruch</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>CNS-specific immunity at the choroid plexus shifts toward
                        destructive Th2 inflammation in brain aging</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.1073/pnas.1211270110</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guerrero-juarez</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Myung</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Inference and analysis of cell-cell communication using
                        CellChat</article-title>
<source>bioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Efremova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vento-Tormo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Teichmann</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Vento-Tormo</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>CellPhoneDB: inferring cell-cell communication from combined
                        expression of multi-subunit ligand-receptor complexes</article-title>
<source>Nat Protoc</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1038/s41596-020-0292-x</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thrupp</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-Nucleus RNA-Seq Is Not Suitable for Detection of
                        Microglial Activation Genes in Humans</article-title>
<source>Cell Rep</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.celrep.2020.108189</pub-id>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trapnell</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>The dynamics and regulators of cell fate decisions are revealed
                        by pseudotemporal ordering of single cells</article-title>
<source>Nat Biotechnol</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.1038/nbt.2859</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammond</surname>
<given-names>TR</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-Cell RNA Sequencing of Microglia throughout the Mouse
                        Lifespan and in the Injured Brain Reveals Complex Cell-State
                        Changes</article-title>
<source>Immunity</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1016/j.immuni.2018.11.004</pub-id>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cochain</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-cell RNA-seq reveals the transcriptional landscape and
                        heterogeneity of aortic macrophages in murine
                        atherosclerosis</article-title>
<source>Circ Res</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.312509</pub-id>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryan</surname>
<given-names>KJ</given-names>
</name>
<etal/>
</person-group>
<article-title>Expression of CD74 is increased in neurofibrillary tangles in
                        Alzheimer's disease</article-title>
<source>Mol Neurodegener</source>
<year>2008</year>
<pub-id pub-id-type="doi">10.1186/1750-1326-3-13</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borghese</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Clanchy</surname>
<given-names>FIl</given-names>
</name>
</person-group>
<article-title>CD74: An emerging opportunity as a therapeutic target in cancer
                        and autoimmune disease</article-title>
<source>Expert Opinion on Therapeutic Targets</source>
<year>2011</year>
<pub-id pub-id-type="doi">10.1517/14728222.2011.550879</pub-id>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathys</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Temporal Tracking of Microglia Activation in Neurodegeneration at
                        Single-Cell Resolution</article-title>
<source>Cell Rep</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.09.039</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hopperton</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Trépanier</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Giuliano</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bazinet</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Markers of microglia in post-mortem brain samples from patients
                        with Alzheimer's disease: A systematic review</article-title>
<source>Molecular Psychiatry</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1038/mp.2017.246</pub-id>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nomura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vilalta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Allendorf</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Hornik</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>Activated Microglia Desialylate and Phagocytose Cells via
                        Neuraminidase, Galectin-3, and Mer Tyrosine Kinase</article-title>
<source>J Immunol</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.4049/jimmunol.1502532</pub-id>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Healy</surname>
<given-names>LM</given-names>
</name>
<etal/>
</person-group>
<article-title>MerTK Is a Functional Regulator of Myelin Phagocytosis by Human
                        Myeloid Cells</article-title>
<source>J Immunol</source>
<year>2016</year>
<pub-id pub-id-type="doi">10.4049/jimmunol.1502562</pub-id>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lew</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Mazzoni</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Finnemann</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Microglia Inhibition Delays Retinal Degeneration Due to MerTK
                        Phagocytosis Receptor Deficiency</article-title>
<source>Front Immunol</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.01463</pub-id>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tondo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Perani</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Comi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>TAM receptor pathways at the crossroads of neuroinflammation and
                        neurodegeneration</article-title>
<source>Disease Markers</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1155/2019/2387614</pub-id>
</element-citation>
</ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>IRAK-M is a negative regulator of Toll-like receptor
                        signaling</article-title>
<source>Cell</source>
<year>2002</year>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)00827-9</pub-id>
</element-citation>
</ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyu</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>IRAK-M deficiency exacerbates ischemic neurovascular injuries in
                        experimental stroke mice</article-title>
<source>Front Cell Neurosci</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.3389/fncel.2018.00504</pub-id>
</element-citation>
</ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deczkowska</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Mef2C restrains microglial inflammatory response and is lost in
                        brain ageing in an IFN-I-dependent manner</article-title>
<source>Nat Commun</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.1038/s41467-017-00769-0</pub-id>
</element-citation>
</ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Complement and microglia mediate early synapse loss in Alzheimer
                        mouse models</article-title>
<source>Science (80-)</source>
<year>2016</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1126/science.aad8373</pub-id>
</element-citation>
</ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stevens</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>The Classical Complement Cascade Mediates CNS Synapse
                        Elimination</article-title>
<source>Cell</source>
<year>2007</year>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.10.036</pub-id>
</element-citation>
</ref>
<ref id="R80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehrman</surname>
<given-names>EK</given-names>
</name>
<etal/>
</person-group>
<article-title>CD47 Protects Synapses from Excess Microglia-Mediated Pruning
                        during Development</article-title>
<source>Neuron</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.neuron.2018.09.017</pub-id>
</element-citation>
</ref>
<ref id="R81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Neher</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Microglial phagocytosis of live neurons</article-title>
<source>Nat Rev Neurosci</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.1038/nrn3710</pub-id>
</element-citation>
</ref>
<ref id="R82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofroniew</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Astrocyte barriers to neurotoxic inflammation</article-title>
<source>Nature Reviews Neuroscience</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.1038/nrn3898</pub-id>
</element-citation>
</ref>
<ref id="R83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owens</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bechmann</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Engelhardt</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Perivascular spaces and the two steps to
                        neuroinflammation</article-title>
<source>Journal of Neuropathology and Experimental Neurology</source>
<year>2008</year>
<pub-id pub-id-type="doi">10.1097/NEN.0b013e31818f9ca8</pub-id>
</element-citation>
</ref>
<ref id="R84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Eroglu</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Cell Biology of Astrocyte-Synapse Interactions</article-title>
<source>Neuron</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.1016/j.neuron.2017.09.056</pub-id>
</element-citation>
</ref>
<ref id="R85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Eroglu</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Astrocytes control synapse formation, function, and
                        elimination</article-title>
<source>Cold Spring Harb Perspect Biol</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.1101/cshperspect.a020370</pub-id>
</element-citation>
</ref>
<ref id="R86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perea</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Navarrete</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Araque</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Tripartite synapses: astrocytes process and control synaptic
                        information</article-title>
<source>Trends in Neurosciences</source>
<year>2009</year>
<pub-id pub-id-type="doi">10.1016/j.tins.2009.05.001</pub-id>
</element-citation>
</ref>
<ref id="R87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eng</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Ghirnikar</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>GFAP and Astrogliosis</article-title>
<source>Brain Pathology</source>
<year>1994</year>
<pub-id pub-id-type="doi">10.1111/j.1750-3639.1994.tb00838.x</pub-id>
</element-citation>
</ref>
<ref id="R88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llorens</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>YKL-40 in the brain and cerebrospinal fluid of neurodegenerative
                        dementias</article-title>
<source>Mol Neurodegener</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.1186/s13024-017-0226-4</pub-id>
</element-citation>
</ref>
<ref id="R89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matute-Blanch</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Chitinase 3-like 1 is neurotoxic in primary cultured
                        neurons</article-title>
<source>Sci Rep</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1038/s41598-020-64093-2</pub-id>
</element-citation>
</ref>
<ref id="R90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno-Rodriguez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Nadeem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Malek-Ahmadi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mufson</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>Frontal cortex chitinase and pentraxin neuroinflammatory
                        alterations during the progression of Alzheimer's disease</article-title>
<source>J Neuroinflammation</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1186/s12974-020-1723-x</pub-id>
</element-citation>
</ref>
<ref id="R91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Role of Excitatory Amino Acid Transporter-2 (EAAT2) and glutamate
                        in neurodegeneration: Opportunities for developing novel
                        therapeutics</article-title>
<source>Journal of Cellular Physiology</source>
<year>2011</year>
<pub-id pub-id-type="doi">10.1002/jcp.22609</pub-id>
</element-citation>
</ref>
<ref id="R92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su zhong</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>Insights into glutamate transport regulation in human astrocytes:
                        Cloning of the promoter for excitatory amino acid transporter 2
                        (EAAT2)</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2003</year>
<pub-id pub-id-type="doi">10.1073/pnas.0136555100</pub-id>
</element-citation>
</ref>
<ref id="R93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maragakis</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Dykes-Hoberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Altered Expression of the Glutamate Transporter EAAT2b in
                        Neurological Disease</article-title>
<source>Ann Neurol</source>
<year>2004</year>
<pub-id pub-id-type="doi">10.1002/ana.20003</pub-id>
</element-citation>
</ref>
<ref id="R94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewerenz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Maher</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Chronic glutamate toxicity in neurodegenerative diseases-What is
                        the evidence?</article-title>
<source>Frontiers in Neuroscience</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.3389/fnins.2015.00469</pub-id>
</element-citation>
</ref>
<ref id="R95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>ZH</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of excitotoxicity and their relevance to
                        pathogenesis of neurodegenerative diseases</article-title>
<source>Acta Pharmacologica Sinica</source>
<year>2009</year>
<pub-id pub-id-type="doi">10.1038/aps.2009.24</pub-id>
</element-citation>
</ref>
<ref id="R96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kullmann</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Asztely</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Extrasynaptic glutamate spillover in the hippocampus: Evidence
                        and implications</article-title>
<source>Trends Neurosci</source>
<year>1998</year>
<pub-id pub-id-type="doi">10.1016/S0166-2236(97)01150-8</pub-id>
</element-citation>
</ref>
<ref id="R97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diamond</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>A broad view of glutamate spillover</article-title>
<source>Nature Neuroscience</source>
<year>2002</year>
<pub-id pub-id-type="doi">10.1038/nn0402-291</pub-id>
</element-citation>
</ref>
<ref id="R98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose</surname>
<given-names>CR</given-names>
</name>
<etal/>
</person-group>
<article-title>Astroglial glutamate signaling and uptake in the
                        hippocampus</article-title>
<source>Frontiers in Molecular Neuroscience</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.3389/fnmol.2017.00451</pub-id>
</element-citation>
</ref>
<ref id="R99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filosa</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Neuron-glia communication via EphA4/ephrin-A3 modulates LTP
                        through glial glutamate transport</article-title>
<source>Nat Neurosci</source>
<year>2009</year>
<pub-id pub-id-type="doi">10.1038/nn.2394</pub-id>
</element-citation>
</ref>
<ref id="R100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>JG</given-names>
</name>
</person-group>
<article-title>Astroglial glutamate transporters coordinate excitatory signaling
                        and brain energetics</article-title>
<source>Neurochemistry International</source>
<year>2016</year>
<pub-id pub-id-type="doi">10.1016/j.neuint.2016.03.014</pub-id>
</element-citation>
</ref>
<ref id="R101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carmona</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Murai</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Pasqualea</surname>
<given-names>EB</given-names>
</name>
</person-group>
<article-title>Glial ephrin-A3 regulates hippocampal dendritic spine morphology
                        and glutamate transport</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2009</year>
<pub-id pub-id-type="doi">10.1073/pnas.0903328106</pub-id>
</element-citation>
</ref>
<ref id="R102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohno</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kinboshi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Inwardly rectifying potassium channel kir4.1 as a novel modulator
                        of BDNF expression in astrocytes</article-title>
<source>International Journal of Molecular Sciences</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.3390/ijms19113313</pub-id>
</element-citation>
</ref>
<ref id="R103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramakrishnan</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Drescher</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Drescher</surname>
<given-names>DG</given-names>
</name>
</person-group>
<article-title>The SNARE complex in neuronal and sensory cells</article-title>
<source>Molecular and Cellular Neuroscience</source>
<year>2012</year>
<pub-id pub-id-type="doi">10.1016/j.mcn.2012.03.009</pub-id>
</element-citation>
</ref>
<ref id="R104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Südhof</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Malenka</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Understanding Synapses: Past, Present, and Future</article-title>
<source>Neuron</source>
<year>2008</year>
<pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.011</pub-id>
</element-citation>
</ref>
<ref id="R105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davison</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Basic Neurochemistry: Molecular, Cellular, and Medical
                        Aspects</article-title>
<source>J Neurol Neurosurg Psychiatry</source>
<year>1989</year>
<pub-id pub-id-type="doi">10.1136/jnnp.52.8.1021-a</pub-id>
</element-citation>
</ref>
<ref id="R106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hess</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Jinnah</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Kozak</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Spontaneous locomotor hyperactivity in a mouse mutant with a
                        deletion including the Snap gene on chromosome 2</article-title>
<source>J Neurosci</source>
<year>1992</year>
<pub-id pub-id-type="doi">10.1523/jneurosci.12-07-02865.1992</pub-id>
</element-citation>
</ref>
<ref id="R107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Sower</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Perrone-Bizzozero</surname>
<given-names>NI</given-names>
</name>
</person-group>
<article-title>Altered levels of the synaptosomal associated protein SNAP-25 in
                        schizophrenia</article-title>
<source>Biol Psychiatry</source>
<year>1998</year>
<pub-id pub-id-type="doi">10.1016/S0006-3223(97)00204-7</pub-id>
</element-citation>
</ref>
<ref id="R108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabriel</surname>
<given-names>SM</given-names>
</name>
<etal/>
</person-group>
<article-title>Increased concentrations of presynaptic proteins in the cingulate
                        cortex of subjects with schizophrenia</article-title>
<source>Arch Gen Psychiatry</source>
<year>1997</year>
<pub-id pub-id-type="doi">10.1001/archpsyc.1997.01830180077010</pub-id>
</element-citation>
</ref>
<ref id="R109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berchtold</surname>
<given-names>NC</given-names>
</name>
<etal/>
</person-group>
<article-title>Synaptic genes are extensively downregulated across multiple
                        brain regions in normal human aging and Alzheimer's disease</article-title>
<source>Neurobiol Aging</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.11.024</pub-id>
</element-citation>
</ref>
<ref id="R110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vardar</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Distinct functions of syntaxin-1 in neuronal maintenance,
                        synaptic vesicle docking, and fusion in mouse neurons</article-title>
<source>J Neurosci</source>
<year>2016</year>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1314-16.2016</pub-id>
</element-citation>
</ref>
<ref id="R111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arancillo</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Titration of Syntaxin1 in mammalian synapses reveals multiple
                        roles in vesicle docking, priming, and release probability</article-title>
<source>J Neurosci</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0187-13.2013</pub-id>
</element-citation>
</ref>
<ref id="R112">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Brain-Specific SNAP-25 Deletion Leads to Elevated Extracellular
                        Glutamate Level and Schizophrenia-Like Behavior in Mice</article-title>
<source>Neural Plast</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.1155/2017/4526417</pub-id>
</element-citation>
</ref>
<ref id="R113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>CSPα knockout causes neurodegeneration by impairing SNAP-25
                        function</article-title>
<source>EMBO J</source>
<year>2012</year>
<pub-id pub-id-type="doi">10.1038/emboj.2011.467</pub-id>
</element-citation>
</ref>
<ref id="R114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vuong</surname>
<given-names>CK</given-names>
</name>
<etal/>
</person-group>
<article-title>Rbfox1 Regulates Synaptic Transmission through the Inhibitory
                        Neuron-Specific vSNARE Vamp1</article-title>
<source>Neuron</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.neuron.2018.03.008</pub-id>
</element-citation>
</ref>
<ref id="R115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schoch</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>SNARE function analyzed in synaptobrevin/VAMP knockout
                        mice</article-title>
<source>Science (80-)</source>
<year>2001</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1126/science.1064335</pub-id>
</element-citation>
</ref>
<ref id="R116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blasi</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Inhibition of neurotransmitter release by clostridial neurotoxins
                        correlates with specific proteolysis of synaptosomal
                        proteins</article-title>
<source>J Physiol - Paris</source>
<year>1994</year>
<pub-id pub-id-type="doi">10.1016/0928-4257(94)90086-8</pub-id>
</element-citation>
</ref>
<ref id="R117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Syntaxin requirement for Ca2+-triggered exocytosis in neurons and
                        endocrine cells demonstrated with an engineered neurotoxin</article-title>
<source>Biochemistry</source>
<year>2011</year>
<pub-id pub-id-type="doi">10.1021/bi200290p</pub-id>
</element-citation>
</ref>
<ref id="R118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Washbourne</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms
                        of neuroexocytosis</article-title>
<source>Nat Neurosci</source>
<year>2002</year>
<pub-id pub-id-type="doi">10.1038/nn783</pub-id>
</element-citation>
</ref>
<ref id="R119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feldmeyer</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Excitatory neuronal connectivity in the barrel
                        cortex</article-title>
<source>Front Neuroanat</source>
<year>2012</year>
<pub-id pub-id-type="doi">10.3389/fnana.2012.00024</pub-id>
</element-citation>
</ref>
<ref id="R120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petersen</surname>
<given-names>CCH</given-names>
</name>
<name>
<surname>Crochet</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Synaptic Computation and Sensory Processing in Neocortical Layer
                        2/3</article-title>
<source>Neuron</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.020</pub-id>
</element-citation>
</ref>
<ref id="R121">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshall</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>How COVID-19 can damage the brain</article-title>
<source>Nature</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1038/d41586-020-02599-5</pub-id>
</element-citation>
</ref>
<ref id="R122">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jäkel</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Altered human oligodendrocyte heterogeneity in multiple
                        sclerosis</article-title>
<source>Nature</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1038/s41586-019-0903-2</pub-id>
</element-citation>
</ref>
<ref id="R123">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Dalahmah</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-nucleus RNA-seq identifies Huntington disease astrocyte
                        states</article-title>
<source>Acta Neuropathol Commun</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1186/s40478-020-0880-6</pub-id>
</element-citation>
</ref>
<ref id="R124">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maurano</surname>
<given-names>MT</given-names>
</name>
<etal/>
</person-group>
<article-title>Systematic localization of common disease-associated variation in
                        regulatory DNA</article-title>
<source>Science (80-)</source>
<year>2012</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1126/science.1222794</pub-id>
</element-citation>
</ref>
<ref id="R125">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nott</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Brain cell type-specific enhancer-promoter interactome maps and
                        disease-risk association</article-title>
<source>Science (80-)</source>
<year>2019</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1126/science.aay0793</pub-id>
</element-citation>
</ref>
<ref id="R126">
<label>126</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buniello</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>The NHGRI-EBI GWAS Catalog of published genome-wide association
                        studies, targeted arrays and summary statistics 2019</article-title>
<source>Nucleic Acids Res</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1093/nar/gky1120</pub-id>
</element-citation>
</ref>
<ref id="R127">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Comprehensive functional genomic resource and integrative model
                        for the human brain</article-title>
<source>Science (80-)</source>
<year>2018</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1126/science.aat8464</pub-id>
</element-citation>
</ref>
<ref id="R128">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>The chandelier neuron in schizophrenia</article-title>
<source>Dev Neurobiol</source>
<year>2011</year>
<pub-id pub-id-type="doi">10.1002/dneu.20825</pub-id>
</element-citation>
</ref>
<ref id="R129">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierri</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Volk</surname>
<given-names>CLE</given-names>
</name>
<name>
<surname>Auh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Decreased somal size of deep layer 3 pyramidal neurons in the
                        prefrontal cortex of subjects with schizophrenia</article-title>
<source>Arch Gen Psychiatry</source>
<year>2001</year>
<pub-id pub-id-type="doi">10.1001/archpsyc.58.5.466</pub-id>
</element-citation>
</ref>
<ref id="R130">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garey</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>When cortical development goes wrong: Schizophrenia as a
                        neurodevelopmental disease of microcircuits</article-title>
<source>J Anat</source>
<year>2010</year>
<pub-id pub-id-type="doi">10.1111/j.1469-7580.2010.01231.x</pub-id>
</element-citation>
</ref>
<ref id="R131">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shrestha</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mousa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heintz</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Layer 2/3 pyramidal cells in the medial prefrontal cortex
                        moderate stress induced depressive behaviors</article-title>
<source>Elife</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.7554/eLife.08752</pub-id>
</element-citation>
</ref>
<ref id="R132">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granato</surname>
<given-names>A</given-names>
</name>
<name>
<surname>De Giorgio</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Alterations of neocortical pyramidal neurons: Turning points in
                        the genesis of mental retardation</article-title>
<source>Frontiers in Pediatrics</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.3389/fped.2014.00086</pub-id>
</element-citation>
</ref>
<ref id="R133">
<label>133</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>
<article-title>Astrocyte, a promising target for mood disorder
                        interventions</article-title>
<source>Frontiers in Molecular Neuroscience</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.3389/fnmol.2019.00136</pub-id>
</element-citation>
</ref>
<ref id="R134">
<label>134</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkowska</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Astrocyte Pathology in Major Depressive Disorder: Insights from
                        Human Postmortem Brain Tissue</article-title>
<source>Curr Drug Targets</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.2174/13894501113149990156</pub-id>
</element-citation>
</ref>
<ref id="R135">
<label>135</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarasov</surname>
<given-names>VV</given-names>
</name>
<etal/>
</person-group>
<article-title>Alterations of astrocytes in the context of schizophrenic
                        dementia</article-title>
<source>Frontiers in Pharmacology</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.3389/fphar.2019.01612</pub-id>
</element-citation>
</ref>
<ref id="R136">
<label>136</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swain</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bhagat</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sahni</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Salunke</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Mechanical ventilation in neurological and neurosurgical
                        patients</article-title>
<source>Neurol India</source>
<year>2016</year>
<pub-id pub-id-type="doi">10.4103/0028-3886.181585</pub-id>
</element-citation>
</ref>
<ref id="R137">
<label>137</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hosseini</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Long-term neuroinflammation induced by influenza a virus
                        infection and the impact on hippocampal neuron morphology and
                        function</article-title>
<source>J Neurosci</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1740-17.2018</pub-id>
</element-citation>
</ref>
<ref id="R138">
<label>138</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casals</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Elizan</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Yahr</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Postencephalitic parkinsonism - A review</article-title>
<source>Journal of Neural Transmission</source>
<year>1998</year>
<pub-id pub-id-type="doi">10.1007/s007020050086</pub-id>
</element-citation>
</ref>
<ref id="R139">
<label>139</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Readhead</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>Multiscale Analysis of Independent Alzheimer's Cohorts Finds
                        Disruption of Molecular, Genetic, and Clinical Networks by Human
                        Herpesvirus</article-title>
<source>Neuron</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.neuron.2018.05.023</pub-id>
</element-citation>
</ref>
<ref id="R140">
<label>140</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deleidi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Isacson</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Viral and inflammatory triggers of neurodegenerative
                        diseases</article-title>
<source>Science Translational Medicine</source>
<year>2012</year>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3003492</pub-id>
</element-citation>
</ref>
<ref id="R141">
<label>141</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yousef</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Aged blood impairs hippocampal neural precursor activity and
                        activates microglia via brain endothelial cell VCAM1</article-title>
<source>Nat Med</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1038/s41591-019-0440-4</pub-id>
</element-citation>
</ref>
<ref id="R142">
<label>142</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>MB</given-names>
</name>
<etal/>
</person-group>
<article-title>Brain Endothelial Cells Are Exquisite Sensors of Age-Related
                        Circulatory Cues</article-title>
<source>Cell Rep</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.celrep.2020.03.012</pub-id>
</element-citation>
</ref>
<ref id="R143">
<label>143</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petersen</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Akassoglou</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Fibrinogen in neurological diseases: Mechanisms, imaging and
                        therapeutics</article-title>
<source>Nature Reviews Neuroscience</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1038/nrn.2018.13</pub-id>
</element-citation>
</ref>
<ref id="R144">
<label>144</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>AC</given-names>
</name>
<etal/>
</person-group>
<article-title>Physiological blood-brain transport is impaired with age by a
                        shift in transcytosis</article-title>
<source>Nature</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1038/s41586-020-2453-z</pub-id>
</element-citation>
</ref>
<ref id="R145">
<label>145</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garrigues</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>Post-discharge persistent symptoms and health-related quality of
                        life after hospitalization for COVID-19</article-title>
<source>Journal of Infection</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.jinf.2020.08.029</pub-id>
</element-citation>
</ref>
<ref id="R146">
<label>146</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaseda</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Post-traumatic stress disorder: a differential diagnostic
                        consideration for COVID-19 survivors</article-title>
<source>Clinical Neuropsychologist</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1080/13854046.2020.1811894</pub-id>
</element-citation>
</ref>
<ref id="R147">
<label>147</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallejo-Illarramendi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Torres-Ramos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Melone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Matute</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Clozapine reduces GLT-1 expression and glutamate uptake in
                        astrocyte cultures</article-title>
<source>Glia</source>
<year>2005</year>
<pub-id pub-id-type="doi">10.1002/glia.20172</pub-id>
</element-citation>
</ref>
<ref id="R148">
<label>148</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swiech</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>In vivo interrogation of gene function in the mammalian brain
                        using CRISPR-Cas9</article-title>
<source>Nat Biotechnol</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.1038/nbt.3055</pub-id>
</element-citation>
</ref>
<ref id="R149">
<label>149</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corces</surname>
<given-names>MR</given-names>
</name>
<etal/>
</person-group>
<article-title>An improved ATAC-seq protocol reduces background and enables
                        interrogation of frozen tissues</article-title>
<source>Nat Methods</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.1038/nmeth.4396</pub-id>
</element-citation>
</ref>
<ref id="R150">
<label>150</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McInnes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Healy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Saul</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Groβberger</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>UMAP: Uniform Manifold Approximation and
                        Projection</article-title>
<source>J Open Source Softw</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.21105/joss.00861</pub-id>
</element-citation>
</ref>
<ref id="R151">
<label>151</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Behjati</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>SoupX removes ambient RNA contamination from droplet based
                        single-cell RNA sequencing data</article-title>
<source>bioRxiv</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.1101/303727</pub-id>
</element-citation>
</ref>
<ref id="R152">
<label>152</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satija</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Farrell</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Gennert</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schier</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Regev</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Spatial reconstruction of single-cell gene expression
                        data</article-title>
<source>Nat Biotechnol</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.1038/nbt.3192</pub-id>
</element-citation>
</ref>
<ref id="R153">
<label>153</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGinnis</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Murrow</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Gartner</surname>
<given-names>ZJ</given-names>
</name>
</person-group>
<article-title>DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing
                        Data Using Artificial Nearest Neighbors</article-title>
<source>Cell Syst</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1016/j.cels.2019.03.003</pub-id>
</element-citation>
</ref>
<ref id="R154">
<label>154</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finak</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>MAST: A flexible statistical framework for assessing
                        transcriptional changes and characterizing heterogeneity in single-cell RNA
                        sequencing data</article-title>
<source>Genome Biol</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.1186/s13059-015-0844-5</pub-id>
</element-citation>
</ref>
<ref id="R155">
<label>155</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>EY</given-names>
</name>
<etal/>
</person-group>
<article-title>Enrichr: Interactive and collaborative HTML5 gene list enrichment
                        analysis tool</article-title>
<source>BMC Bioinformatics</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.1186/1471-2105-14-128</pub-id>
</element-citation>
</ref>
<ref id="R156">
<label>156</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Metascape provides a biologist-oriented resource for the analysis
                        of systems-level datasets</article-title>
<source>Nat Commun</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id>
</element-citation>
</ref>
<ref id="R157">
<label>157</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerstner</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>GeneTrail 3: advanced high-throughput enrichment
                        analysis</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1093/nar/gkaa306</pub-id>
</element-citation>
</ref>
<ref id="R158">
<label>158</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bost</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Host-Viral Infection Maps Reveal Signatures of Severe COVID-19
                        Patients</article-title>
<source>Cell</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.05.006</pub-id>
</element-citation>
</ref>
<ref id="R159">
<label>159</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Breitwieser</surname>
<given-names>FP</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>SL</given-names>
</name>
</person-group>
<source>Genome Res</source>
<year>2016</year>
<pub-id pub-id-type="doi">10.1101/gr.210641.116</pub-id>
</element-citation>
</ref>
<ref id="R160">
<label>160</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Beke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Klucar</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>ViruSITE - Integrated database for viral genomics</article-title>
<source>Database</source>
<year>2016</year>
<pub-id pub-id-type="doi">10.1093/database/baw162</pub-id>
</element-citation>
</ref>
<ref id="R161">
<label>161</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wauters</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<source>Discriminating Mild from Critical COVID-19 by Innate and Adaptive Immune
                        Single-cell Profiling of Bronchoalveolar Lavages</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.07.09.196519</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Cell type-specific gene expression changes in the brain of COVID-19
                    patients.</title>
<p>
                    <bold>a</bold>, Study design. Colored triangles denote brain regions studied for
                    each patient.</p>
<p>
                    <bold>b</bold>, Uniform Manifold Approximation and Projection (UMAP) of 23,626
                    nuclei captured from the human medial frontal cortex, colored by cell type and
                    labeled with percent of total nuclei. Note, that as in priorreports<sup>
<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R35">35</xref>
</sup>, the ‘Endothelial’ cluster also exhibits vascular mural cell markers.</p>
<p>
                    <bold>c</bold>, Differentially expressed gene (DEG) counts for each cell type
                    (MAST with default thresholds, FDR &lt; 0.05, Log (fold change) &gt; 0.25
                    (absolute value)). The intensity of the blue color and the size of thesquares
                    are proportional to entry values.</p>
<p>
                    <bold>d</bold>, Example differentially expressed genes (DEGs) in COVID-19:
                    excitatory (Ex N) and inhibitory (In N) neurons, astrocytes (Ast),
                    oligodendrocytes (Oli), oligodendrocyte precursor cells (OPC), and
                    microglia(Mic).</p>
<p>
                    <bold>e</bold>, Matrix layout for intersections of DEGs shared across and
                    specific to each cell type. Circles in the matrix indicate sets that are part of
                    the intersection, showing that most DEGs are cell type-specific.</p>
<p>
                    <bold>f</bold>, Fraction of total up- and downregulated genes (y-axis) as a
                    function of the total number of cell types in which the differential expression
                    occurs. Biological pathways associated with genes downregulated in COVID-19 that
                    are common to ≥2 cell types are shown (<italic>n</italic> = 161 genes,
                    hypergeometric test, FDRcorrection).</p>
</caption>
<graphic xlink:href="EMS100941-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>SARS-CoV-2 infection of blood-brain and -CSF barrier cells.</title>
<p>
                    <bold>a</bold>, SARS-CoV-2 spike glycoprotein (brown) detection in the frontal
                    medial cortex of two COVID-19 patients in tissue immediately adjacent to that
                    used for snRNA-seq. Hematoxylin counterstain (blue).Scale bar = 20 microns.</p>
<p>
                    <bold>b</bold>, As in (<bold>a</bold>) but for the meninges in Patient 2. Scale
                    bar = 20 microns.</p>
<p>
                    <bold>c</bold>, As in (<bold>a</bold>) but for the choroid plexi immediately
                    adjacent to tissue used for snRNA-seq, in Patient 1. Scale bar = 20 microns.</p>
</caption>
<graphic xlink:href="EMS100941-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Viral defense and inflammatory signaling in blood-CSF barrier cells.</title>
<p>
                    <bold>a</bold>, UMAP of 24,052 nuclei captured from the human lateral choroid
                    plexus, colored by cell type and labeled with percent of total nuclei.</p>
<p>
                    <bold>b</bold>, Expression profiles (CPM, circle size) and differential
                    expression in COVID-19 patients (Log (fold change), color) for genes relevant to
                    SARS-CoV-2 brain entry<sup>
<xref ref-type="bibr" rid="R16">16</xref>
</sup>. Grey indicates genes consistently upregulated in either brain-barrier
                    cells (<italic>IFITM3</italic>) or cortex (<italic>NRP1</italic>).</p>
<p>
                    <bold>c</bold>, DEG counts for each cell type (MAST, FDR &lt; 0.05, Log (fold
                    change) &gt; 0.25 (absolute value)). The intensity of the blue color and the
                    size of the squares are proportional to entry values.</p>
<p>
                    <bold>d</bold>, Example DEGs in COVID-19 choroid plexus.</p>
<p>
                    <bold>e</bold>, Matrix layout for intersections of DEGs shared across and
                    specific to each cell type.</p>
<p>
                    <bold>f</bold>, Circle plot showing the number of statistically significant
                    intercellular signaling interactions for the CCL and CXCL family of molecules in
                    controls (non-viral and influenza) compared to COVID-19 patients (permutation
                    test, CellChat<sup>
<xref ref-type="bibr" rid="R61">61</xref>
</sup>).</p>
</caption>
<graphic xlink:href="EMS100941-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>Immune cell infiltration and activation of microglial phagocytosis programs
                    in COVID-19 brains.</title>
<p>
                    <bold>a</bold>, UMAP of 1,154 immune cells captured in the human frontal cortex,
                    split by non-viral controls, influenza, and COVID-19 patients. Cells are colored
                    by cell type subcluster. Example genes upregulated inMicroglia cluster 2 are
                    shown.</p>
<p>
                    <bold>b</bold>, Quantification of Microglia 2 population as a proportion of
                    total immune cells (<italic>n</italic> = 5 controls, including influenza;
                        <italic>n</italic> = 4 COVID-19, two-sided t-test; mean +/- s.e.m.).</p>
<p>
                    <bold>c</bold>, Monocle<sup>
<xref ref-type="bibr" rid="R64">64</xref>
</sup> pseudotime trajectory plotting the emergence of Microglia cluster 2.
                    Pseudotime is indicated in graded purple (high) to yellow (high). Numbers
                    indicate Microglial cluster from (<bold>a</bold>).</p>
<p>
                    <bold>d</bold>, Quantification of the T-cell population as a proportion of total
                    immune cells (<italic>n</italic> = 5 controls, including influenza;
                        <italic>n</italic> = 4 COVID-19, two-sided t-test; mean +/- s.e.m.).</p>
<p>
                    <bold>e</bold>, Expression of the established peripheral macrophage-specific
                    marker <italic>F13A1</italic>
                    <sup>
<xref ref-type="bibr" rid="R65">65</xref>,<xref ref-type="bibr" rid="R66">66</xref>
</sup>. Expression (logCPM) is indicated in graded purple (left). Quantification
                    of the peripheral macrophage population as a proportion of total immune cells
                        (<italic>n</italic> = 5 controls, including influenza; <italic>n</italic> =
                    4 COVID-19, two-sided t-test; mean +/-s.e.m., right).</p>
<p>
                    <bold>f,</bold> Expression of established microglial activation<sup>
<xref ref-type="bibr" rid="R67">67</xref>–<xref ref-type="bibr" rid="R74">74</xref>
</sup> and inflammation checkpoint<sup>
<xref ref-type="bibr" rid="R75">75</xref>–<xref ref-type="bibr" rid="R77">77</xref>
</sup> molecules. Violin plots are centered around the median, with their shape
                    representing cell distribution (***<italic>P &lt;</italic> 0.001,
                        ****<italic>P</italic> &lt; 0.00001, MAST).</p>
<p>
                    <bold>g</bold>, Upregulation of genes mediating the microglial phagocytosis of
                    live neurons<sup>
<xref ref-type="bibr" rid="R81">81</xref>
</sup>. Bold indicates upregulated genes in COVID-19, grey not detected.</p>
</caption>
<graphic xlink:href="EMS100941-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<title>Impaired astrocytic support and excitatory neurotransmission in COVID-19
                    cortex.</title>
<p>
                    <bold>a</bold>, Upregulation of inflammatory and dysregulation of homeostatic
                    genes in COVID-19 astrocytes (<italic>n = gical pathways (Elsevier Pathway
                        Collection, Enrichr) amongst upregulated genes in</italic>3,967).</p>
<p>
                    <bold>b</bold>, Enriched biological pathways (Elsevier Pathway Collection,
                    Enrichr) amongst upregulated genes in COVID-19 astrocytes. Enrichment is based
                    on FDR-corrected cumulative hypergeometric <italic>P</italic> values, with a
                    0.25 (absolute value), adjusted <italic>P</italic> value-thresholded DEG
                    gene-marker list (Log (fold change) &gt; 0.25 (absolute value), adjusted
                        <italic>P</italic> value (Bonferroni correction) &lt; 0.05, MAST).</p>
<p>
                    <bold>c</bold>, UMAP of 3,967 astrocytes captured in the human frontal cortex,
                    split by non-viral controls, influenza, and COVID-19 patients. Cells are colored
                    by cell type subcluster. Example genes upregulated in Astrocyte cluster 3 are
                    shown.</p>
<p>
                    <bold>d</bold>, Quantification of Astrocyte 3 population as a proportion of all
                    astrocytes (<italic>n</italic> = 5 controls, including influenza;
                        <italic>n</italic> = 4 COVID-19, two-sided t-test excluding influenza
                    patient; mean +/- s.e.m.).</p>
<p>
                    <bold>e</bold>, Expression of homeostatic astrocyte glutamate transporter genes
                    encoding EEAT2 (<italic>SLC1A2</italic>) and EEAT1 (<italic>SLC1A3</italic>).
                    Violin plots are centered around the median, with their shape representing cell
                    distribution (****<italic>P &lt;</italic> 0.0001, MAST).</p>
<p>
                    <bold>f</bold>, Downregulation of major SNARE components in COVID-19 excitatory
                    neurons (<italic>n</italic> = 7,680 excitatory neurons).</p>
<p>
                    <bold>g</bold>, Heatmap showing downregulation of synaptic vesicle components
                    specifically in COVID-19 L2/3 excitatory neurons (<italic>n</italic> = 7,680
                    excitatory neurons; <italic>n</italic> = 4,948 L2/3 excitatory neurons, Log
                    (fold change) &gt; 0.25 (absolute value), adjusted <italic>P</italic> value
                    (Bonferroni correction) &lt; 0.05, MAST).</p>
</caption>
<graphic xlink:href="EMS100941-f005"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption>
<title>Association of COVID-19 gene expression changes with chronic CNS
                    disease.</title>
<p>
                    <bold>a</bold>, Proportion of COVID-19 DEGs across cell types that are also DEGs
                    in chronic CNS diseases, as published for Alzheimer's Disease (AD)<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup>, Autism spectrum disorder (ASD)<sup>
<xref ref-type="bibr" rid="R33">33</xref>
</sup>, Huntington's disease (HD)<sup>
<xref ref-type="bibr" rid="R123">123</xref>
</sup>, and Multiple sclerosis (MS)<sup>
<xref ref-type="bibr" rid="R122">122</xref>
</sup>. Bars labeled with percent overlapping and over-representation
                        <italic>P</italic> values (cumulative hypergeometric test).</p>
<p>
                    <bold>b</bold>, Heatmap showing the number of differentially expressed genes
                    (DEGs) per cell type that are also GWAS risk variants across psychiatric and
                    neurological diseases and traits from the GWAS catalog (NHGRI-EBI)<sup>
<xref ref-type="bibr" rid="R126">126</xref>
</sup>. Significance is based on FDR-corrected cumulative hypergeometric
                        <italic>P</italic> values, with a <italic>P</italic>value-thresholded DEG
                    list (Log (fold change) &gt; 0.25 (absolute value), adjusted <italic>P</italic>
                    value (Bonferronicorrection) &lt; 0.05, MAST). ALS: Amyotrophic lateral
                    sclerosis, MSA: Multiple system atrophy, ADHD: Attention deficit hyperactivity
                    disorder, and PTSD: Post-traumatic stress disorder.</p>
</caption>
<graphic xlink:href="EMS100941-f006"/>
</fig>
</floats-group>
</article>
